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Objectives 
Oral spirochetes are composed of an enormously heterogeneous group of 
Treponema species, and some have been implicated in the etiology of periodontitis. 
Multiple species or phylotypes of Treponema have often been found in a single 
patient or a single periodontal pocket. Some outer membrane proteins (OMPs) of 
oral spirochetes are important in immune modulation, which has been 
demonstrated in molecular pathogenesis studies. Tp92 of T. pallidum, a surface 
protein, has been reported to have opsonic potential and to induce a protective 
immune response against syphilis, T. pallidum infection. It has been reported that 
 
 
the Tp92 homologs are a family of highly conserved OMPs in gram-negative 
bacteria that may have conserved functions. It is therefore important to find 
common virulence determinants that are localized on the surface of oral spirochetes 
and to characterize them in order to elucidate their role in periodontal pathogenesis. 
The pro-inflammatory and bone-resorptive characteristics of IL-1β are associated 
with the immunopathology of periodontitis, leading to periodontal tissue 
destruction. IL-1β secretion is required for caspase-1 activation, which is 
associated with the inflammasome, which contributes to innate immunity. In this 
study, Tp92 homologs of four representative oral spirochetes (T. denticola, T. 
lecithinolyticum, T. maltophilum, and T. socranskii subsp. socranskii), which are 
strongly associated with periodontitis, were identified and characterized for their 
virulence. 
Methods 
Tp92 homologs from oral spirochetes were expressed in Escherichia coli, and 
the recombinant proteins were purified. To assess the binding ability of the Tp92 
homologs to KB cells (ATCC CCL-17), a carcinoma epithelial cell line was 
incubated with the FITC-labeled Tp92 homologs or carboxyfluorescein diacetate 
succinimidyl ester (CFSE)-labeled bacteria. The cross-reactivity of the Tp92 
homologs was detected with antiserum (IgG fraction) against Td92, a Tp92 
homolog from T. denticola. The biological activities of the Tp92 homologs were 
analyzed by assessing the expression of various factors regarding inflammation and 
 
 
tissue destruction in a human monocytic cell line (THP-1) and periodontal ligament 
cells (PDL cells). 
To identify the molecular mechanisms of T. denticola Td92-induced IL-1β 
secretion, PMA-differentiated THP-1 cells were stimulated with Td92 in the 
presence or absence of KCl, oxATP, and K+ channel blockers, and then, caspase-1 
activation, proIL-1β expression, and IL-1β secretion were determined. The 
components of the inflammasome involved in Td92-induced caspase-1 activation 
were examined using siRNA against NLRP3, ASC, and NLRC4. To determine 
whether Td92 internalization is a prerequisite for NLRP3 activation, Td92 was 
internalized into the cells using protein transfection reagents or in the presence or 
absence of cytochalasin D. A cellular receptor that binds to Td92 and results in 
inflammasome activation was identified using an affinity ligand-binding assay. To 
determine which signaling pathway contributes to the Td92-induced pro-IL-1β 
expression following Td92 binding to the cellular receptor, MAPK pathway 
activation and NF-κB translocation were determined by immunoblotting and 
confocal microscopy in the presence or absence of various inhibitors or 
neutralizing Abs.  
Results 
The Tp92 homologs of the four oral spirochetes had signal peptides (20-31 
amino acids) and molecular masses of 88-92-kDa for the mature proteins. The tp92 
gene homologs were successfully expressed in E. coli, and the recombinant 
proteins were capable of binding to KB cells. Furthermore, the binding of the 
 
 
bacteria to the cells was inhibited by the addition of T. denticola Td92. An 
antiserum (IgG fraction) raised against T. denticola Td92 cross-reacted with the 
Tp92 homologs from the three other species of treponemes, including T. 
lecithinolyticum, T. maltophilum, and T. socranskii subsp. socranskii. The Tp92 
homologs stimulated various factors involved in inflammation and 
osteoclastogenesis, such as IL-1β, IL-6, IL-8, TNF-α, COX-2, PGE2, and MMP-9, 
in host cells, including monocytes and fibroblasts.  
T. denticola Td92 could activate caspase-1, pro-IL-1β, and IL-1β secretion, 
which resulted from ATP release and K+ efflux. Td92-induced caspase-1 activation 
was markedly decreased by the knockdown of NLRP3 or ASC, while the 
knockdown of NLRC4 did not affect Td92-induced caspase-1 activation. The rapid 
uptake of Td92 by a protein transfection reagent into the cells decreased Td92-
induced caspase-1 activation, and blocking Td92 internalization by treatment with 
cytochalasin D did not affect caspase-1 activation or proIL-1β expression. Integrin 
α5β1 played a critical role in NLRP3 inflammasome activation because integrin 
α5β1 is a receptor for T. denticola Td92. Although Td92 was able to bind integrin 
α5β1 and fibronectin, Td92-induced NLRP3 inflammasome activation was 
mediated via direct binding to integrin α5β1, independent of fibronectin binding. 
The integrin α5β1 priming by Td92 led to the induction of pro-IL-1β expression, 






Td92 directly interacts with integrin α5β1 to activate the NLRP3 
inflammasome and upregulate proIL-1β synthesis, which could lead to 
uncontrolled IL-1β secretion. Therefore, integrin α5β1 could be regarded as a 
principal cell membrane receptor for both NLRP3 inammasome activation and 
IL-1β transcription by Td92. Understanding of the interaction between Td92 and 
integrin α5β1 may contribute to the development of a new therapeutic target for 
periodontitis treatment.  
 
Keywords:  Oral spirochetes, Tp92 homologs, Inflammation, NLRP3  
            inflammasome, Integrin α5β1, Periodontitis. 











1. Introduction                                                     1 
2. Materials and Methods                                            7 
2.1. Chemicals and antibodies                                            7 
 2.2. Bacterial strains and growth conditions                                  9 
2.3. Cell culture and treatment                                            9 
2.4. Sequencing of tp92 homologs                                         11 
2.5. Cloning and expression of tp92 homologs, Td-G, and Td-B domain          12 
2.6. Verification of endotoxin decontamination in the recombinant proteins        16 
2.7. Production of antiserum against Tp92 homolog of T. denticola              18 
2.8. Preparation of outer membrane of T. denticola                           19 
2.9. Immunoblotting                                                                20 
2.10. Immunodot blotting                                                           22 
2.11. Indirect immunofluorescence microscopy                                  22 
2.12. Immunogold staining of T. denticola                                          24 
2.13. Fluorescence labeling of protein and bacteria                           25 
2.14. Cell binding and internalization assay                                 25 
2.15. Real-time qPCR                                                  27 
2.16. Gelat in zymography                                              29 
 
 
2.17. Determination of ROS level                                        29 
2.18. Determination of extracellular ATP level                                     30 
2.19. RNA interference assay                                            31 
2.20. Protein transfection                                               32 
2.21. Determination of cell death                                                33 
2.22. Ligand-binding assay                                              34 
2.23. Detection of fibronectin in macrophages and monocytes                 35 
2.24. Endoglycosidase digestion and tunicamycin treatment of THP-1 cells       36 
2.25. Blocking of Td92-induced signaling with the neutralizing intergrin α5β1 Ab    37 
2.26. Fibronectin binding assay                                               38 
2.27. Intergrin α5β1 detection by immunofluorescent staining                  38 
2.28. NF-κB activation assay                                           39 
2.29. Enzyme-linked immunosorbent assay (ELISA)                          41 
2.30. Statistical analysis                                                 41 
2.31. Nucleotide sequence accession number                                 41 
3. Results                                                         42 
3.1. Identification and characterization of Tp92 homologs of oral treponemes      42 
3.1.1. Distribution of tp92 gene homologs in oral treponemes           42 
Table 1. Degrees of amino acid sequence homology of the Tp92 homologs    44 
3.1.2. Purification of recombinant Tp92 homologs                          45 
3.1.3. Cross-reactivity of Tp92 homologs with antiserum raised against Td92    47 
 
 
3.1.4. Outer membrane location of Td92 in T. denticola                     49 
3.1.5. Binding of the Tp92 homologs to KB cells                          56 
3.1.6. Host cell responses to the Tp92 homologs                           59 
3.2. A novel function of integrin α5β1 in the activation of innate immune 
   components by Td92                                              64 
3.2.1. Activation of caspase-1 and IL-1β by T. denticola and Td92             64 
3.2.2. Td92-induced caspase-1 activation via the NLRP3 inflammasome          75 
3.2.3. ROS generation by Td92                                      78 
3.2.4. Association of ATP with Td92-induced caspase-1                     81 
3.2.5. K+ efflux as a mechanism of Td92-induced inflammasome activation     83 
3.2.6. Caspase-1-dependent proinflammatory cell death by Td92              85 
3.2.7. Effect of intracellular delivery of Td92 on caspase-1 activation          88 
3.2.8. Activation of NLRP3 inflammasome by Td92 via interaction with  
the cellular receptor integrin α5β1                                   94 
3.2.9. NF-κB activation by Td92 for the proIL-1β expression and NLRP3  
     activation                                                      124 
4. Discussion                                                    135 
5. Conclusion                                                               149 
6. References                                                               150 




Numerous studies examining epidemiology and virulence factors have 
revealed strong evidence for the role of oral spirochetes in the etiology of 
periodontitis, and the presence of spirochetes in the subgingival plaque is 
associated with an increased severity of periodontitis [1-3]. Oral spirochetes are 
composed of highly heterogeneous Treponema species and are found in high 
numbers in periodontitis patients. Due to their distinctive morphotypes and the 
virulence of Treponema species, oral spirochetes have been used as indicators of 
the active progress of periodontitis using microscopic analysis of subgingival 
plaques. However, only 10 species of Treponema can be cultivated, whereas more 
than 50 phylotypes of oral treponemes have been identified by culture-independent 
methods [4]. Some species, such as T. denticola, T. lecithinolyticum, and T. 
socranskii, are more prevalently associated with periodontitis and are resistant to 
periodontal therapy [2]. Multiple species or phylotypes of Treponema have often 
been found in a single patient or in a single site. The molecular pathogenesis of oral 
treponemes demonstrates that some surface proteins are important immune 
modulators [5-9]. 
The bacterial outer membrane provides a crucial contact barrier to host cells, 
and outer membrane proteins (OMPs) belong to the primary class of molecules 
involved in host-bacteria interactions. They are involved in the adhesion to and the 
induction of cytopathic effects on host cells and in inflammatory and 
immunological responses. OMPs are valuable candidates for the study of host-
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pathogen interactions and for identify appropriate targets for therapy and 
prophylaxis. It is therefore important to identify and characterize common 
virulence determinants that are localized on the surface of oral spirochetes to 
elucidate their role in periodontal pathogenesis. OMPs of oral spirochetes have 
been reported to participate in the colonization, cytopathogenesis, and 
inflammatory responses of the host in periodontitis [6, 10, 11]. Most of the OMPs 
identified in oral spirochetes are species-specific [6, 11-17]. 
Tp92 (837 aa residues), one of the surface antigens of Treponema pallidum, 
with a molecular mass of 92-kDa, has been reported to have opsonic potential and 
to induce a protective immune response to syphilis, a T. pallidum infection [18]. 
This protein has been suggested for use as a syphilis serodiagnostic marker, and it 
has shown a 98% sensitivity and 97% specificity when tested for this capacity [19]. 
Tp92-related proteins are also found in other genera of spirochetes, such as 
Borrelia burgdorferi and Leptospira interrogans, and they are distributed in a wide 
range of gram-negative bacteria, such as Chlamydia trachomatis (OMP85 analog), 
Neisseria spp. (Omp85), Pasteurella multocida (Oma87), Haemophilus spp. (D15), 
and Helicobacter pylori (D15)[20]. Based on functional analysis, Omp85 of 
Neisseria spp. appears to be essential for the viability of the bacteria and to be 
involved in the assembly of outer membrane proteins, such as the porines PorA and 
PorB, secretin PilQ, and the siderophore receptors FrpB and RmpM [21], as well as 
in lipid transport to the outer membrane [22]. Immunization with D15 
Haemophilus spp. was shown to be protective against infection with this bacterium 
in animal models and has been considered as a potential vaccine candidate [23], as 
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shown in T. pallidum with Tp92 [18]. Antiserum against Oma87 of P. multocida 
and D15 of H. influenzae has been found to be immunoprotective in animal models 
[24, 25]. Tp92/Omp85 homologs are therefore a family of highly conserved outer 
membrane proteins in gram-negative bacteria with possibly conserved functions. 
Periodontitis is characterized by bone resorption leading to tooth loss. 
Osteoclasts and osteoblasts play important roles in bone resorption, and 
osteoblastic cells regulate the differentiation, fusion and activation of osteoclasts. 
Osteoclasts are activated by the receptor activator of nuclear factor-κB ligand 
(RANKL), which is stimulated from osteoblasts/stromal cells by osteoclastogenic 
factors, such as parathyroid hormone, 1,25(OH)2 vitaminD3, interleukins (IL-1, IL-
6, IL-11), tumor necrosis factor-α (TNF-α) and prostaglandin E2 (PGE2) [26, 27]. 
The pro-inflammatory and bone-resorptive characteristics of IL-1β are associated 
with the immunopathology of periodontitis, leading to periodontal tissue 
destruction. The IL-1β level is increased in the gingival crevicular fluid of 
periodontitis patients and correlates with the presence of major 
periodontopathogens, such as Porphyromonas gingivalis, Tannerella forsythia, and 
Treponema denticola, which are known collectively as red complex according to 
the classification by Socranskii et al. [3, 28], and with disease severity as assessed 
by bleeding upon probing, probing depth, and gingival attachment loss [29, 30]. 
Significantly elevated IL-1β secretion was observed in a coculture composed of 
epithelial cells and macrophages that was infected with the red complex [31]. An 
IL-1β polymorphism (3954, CT or TT) has been demonstrated to be related to 
significantly higher IL-1β mRNA expression in gingival tissues comprising the 
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junctional epithelium, gingival crevicular epithelium, and connective gingival 
tissue when compared to the wild type (CC) [30]. Gingival tissues with the IL-1β 
polymorphism have been shown to have increased inflammation in response to 
plaque bacteria, leading to an increase in the gingival crevicular fluid flow, which 
supplies rich nutrients for peptidolytic periodontopathogens. Socransky et al. [28] 
found that periodontopathogens, primarily of the red and orange complexes, were 
detected at significantly higher levels in IL-1 genotype-positive subjects than in 
genotype-negative subjects.  
IL-1β secretion is regulated in two separate steps. Upon the binding of 
pathogen recognition receptors with ligands, the transcription of the IL-1β gene is 
increased, and proIL-1β (31 kDa) is synthesized in the cell. The processing of the 
“pro” form into the mature form (17 kDa) requires the assembly and activation of a 
caspase-1-activating complex, the inflammasome. The inflammasome is a 
component of innate immunity and a multiprotein complex that contains 
nucleotide-binding oligomerization domain-like receptors (NLRs), which sense 
pathogens or their components. NLRs are pathogen recognition receptors that are 
intracellularly localized and that detect pathogen-associated molecular patterns, 
pathogen-specific factors, or host danger signals induced by pathogens. Recently, 
the signals and mechanisms leading to inflammasome activation have been 
intensively studied, and NLRs, such as NALP, NLRC4/IPAF, and NAIP, have 
been reported to be involved in caspase-1 activation [32]. Of those NLRs, NLRP3 
(also known as Nalp3 and cryopyrin) has been the most intensively studied, and 
there are a broad range of NLRP3-activating stimuli: pathogen-associated 
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molecules, such as bacterial muramyl dipeptide (MDP), nucleic acids, and bacterial 
pore-forming toxins; danger-associated molecular patterns, such as ATP, 
hyaluronan, glucose, and monosodium urate crystals from the host as a result of 
cellular stress or damage; calcium pyrophosphate dehydrate; and environmental 
irritants, such as silica, asbestos, aluminum hydroxide, and imidazoquinoline [33-
39]. Although IL-1β is required for host defense against pathogens, exaggerated 
expression and secretion of this molecule can lead to tissue damage. Dysregulated 
inflammasome activation is associated with the pathogenesis of a variety of 
inflammatory diseases [40].  
Integrins are heterodimeric glycoprotein receptors composed of alpha and beta 
subunits. In mammals, 24 integrins, with 18 alpha and 8 beta subunits, have been 
identified to date [41]. Integrins mediate cell-cell or cell-extracellular matrix 
interactions, and the binding of integrin to ligands has pivotal roles in normal 
cellular functions, such as cell proliferation, differentiation, and migration, as well 
as in the pathogenesis of chronic inflammation and cancer. A variety of 
microorganisms, including bacteria, viruses, and fungi, use integrins to bind to and 
invade host cells either directly or indirectly. 
The aim of this study is to identify and characterize the Tp92 homologs of 
four representative oral spirochetes that are strongly associated with periodontitis 
and to examine the function in pathogenesis of the common surface proteins of oral 
treponemes in the progression of chronic periodontitis. First, the tp92 gene 
homologs were identified either from the genome sequence (in the case of T. 
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denticola) or by PCR amplification and sequencing, and the activities of the Tp92 
homologs were assessed after cloning the tp92 gene homologs into Escherichia 
coli and purifying the recombinant proteins. The amino acid sequences of the Tp92 
homologs from the oral treponemes were highly homogenous. The immune cross-
reactivity and the surface exposure of the Tp92 homologs in oral treponemes were 
demonstrated with a polyclonal antibody raised against the Tp92 homolog of T. 
denticola. The Tp92 homologs were then shown to bind to epithelial cells and 
induce the expression of proinflammatory and osteoclastogenic factors in host cells, 
including monocytes and fibroblasts. Second, a novel function of integrin α5β1 in 
the activation of innate immune components by Td92, a Tp92 homolog of T. 
denticola, was investigated in PMA-differentiated THP-1 cells, in a human 
monocytic cell line, and in human PBMC-derived macrophages. Td92 directly 
interacts with integrin α5β1 to activate the NLRP3 inflammasome and to 
upregulate proIL-1β synthesis, which could lead to uncontrolled IL-1β secretion. 
Td92 internalization into the cells is not required for this activity, and ATP release 
and K+ efflux induced by Td92 are key functional factors. The involvement of 
integrin α5β1 in NLRP3 inflammation is strengthened by the fact that fibronectin 
and the arginine-glycine-aspartate (RGD) peptide induce caspase-1 activation via 






2. Materials and Methods 
2.1. Chemicals and antibodies  
Chemicals and antibodies were purchased from the sources listed below. 
Phorbol 12-mystristate 13-acetate (PMA), muramyldipeptide (MDP), ATP, oxATP, 
trichloroacetate (TCA), glybenclamide, tolbutamide, human plasma fibronectin, 
propidium iodide, cytochalasin D, N-p-Tosyl-L-phenylalanine chloromethyl ketone 
(TPCK), BAY-117082, tunicamycin from Streptomyces sp., N-glycosidase F from 
Elizabethlingia miricola, Fluorescent probe 2,7-dichlorofluorescein diacetate. 
(DCF-DA), N-acetyl-L-cysteine (NAC), Pyrrolidine dithiocarbamate (PDTC), 
Apocynin, Diphenylene iodonium (DPI), and the monoclonal anti-human 
fibronectin Ab (IST-3) used for immunoblotting were from Sigma (St. Louis, MO, 
USA). S. typhimurium flagellin and ultra pure LPS were from InvivoGen (San 
Diego, CA, USA). Ac-YVAD-cho, SB202190, SB203580, SP600125, PD98059, 
GRGDSP peptide, and GRADSP peptide were from Calbiochem (San Diego, CA, 
USA). Profect P1 was from Targeting Systems (El Cajon, CA, USA). The anti-
human NLRP3 Ab and anti-human TLR4 Ab were from Santa Cruz (Santa Cruz, 
CA, USA). The anti-human ASC Ab was from MBL (Nagoya, Japan). The anti-
human NLRC4 Ab was from ProSci (Poway, CA, USA). Z-YVAD-fmk and the 
LDH-cytotoxicity assay Kit were from BioVision (Palo Alto, CA, USA). The anti-
human integrin α5β1 Ab (monoclonal, JBS5), the anti-human fibronectin blocking 
Ab (monoclonal, 3E3), the anti-human integrin ανβ3 Ab (monoclonal, LM609), 
and Protein G agarose were from Chemicon (Temecula, CA, USA). The anti-(his)5 
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Ab and Ni-NTA agarose were from QIAGEN (Valencia, CA, USA). The affinity 
purified mouse IgG1 isotype control was from eBioscience (San Diego, CA, USA). 
The anti-human caspase-1 Ab (recognizing pro-caspase-1 p45 and caspase-1 p20), 
the anti-human IL-1β Ab (recognizing p17 and p31), antibodies against human 
integrin α5 (polyclonal, cat. no. 4705), integrin β1 (polyclonal, cat. no. 4706), 
integrin αν (polyclonal, cat. no. 4711), integrin β3 (polyclonal, cat. no. 4702), IκBα, 
phospho-p38 (Thr180/Tyr182), phospho-SAPK/JNK (Thr183/Tyr185), phospho-
p44/42 MAP kinase (Thr202/Thr204), TRIF Ab, and MyD88 Ab were from Cell 
Signaling Technology (Beverly, MA,USA). The NF-κB p65 Ab was from Abcam 
(Cambridge, MA, USA). Ficoll-Paque PLUSTM was from Amersham Biosciences 
(Piscataway, NJ, USA). Human AB serum was from Bio Whittaker (Walkersville, 
MD, USA). Recombinant human integrin α5β1, Recombinant human ανβ3, 
recombinant TNF-α, and the human IL-1β ELISA Kit were from R&D Systems 
(Minneapolis, MN, USA). The ATP bioluminescence assay kit and protease 
inhibitor cocktail were from Roche (Mannheim, Germany). Hoechst 33277, 
Carboxyfluorescein diacetate, succinimidyl ester (5(6)-CFSE), Stealth siRNA (for 
NLRP3, NLRC4, ASC, TLR4, integrin α5, MyD88 and TRIF), the Stealth siRNA 
negative control duplex and Lipofectamine RNAiMAX were from Invitrogen 
(Carlsbad, CA, USA). DyLight 488 NHS Ester and the bicinchoninic acid (BCA) 
protein assay Kit were from Pierce (Rockford, IL, USA). The LAL endochrome 
Kit was from Charles River Endosafe (Wilmington, MA, USA). Biotinylated 




2.2. Bacterial strains and growth conditions 
Oral treponemes (T. denticola ATCC 33521, T. lecithinolyticum ATCC 
700332, T. maltophilum ATCC 51939, and T. socranskii subsp. socranskii ATCC 
35536) were cultured in an anaerobic atmosphere (10% CO2, 5% H2, and 85% N2) 
using OMIZ-Pat medium as described previously [42]. E. coli DH5α-T1 
(Invitrogen, Carlsbad, CA, USA) was used for TA cloning and E. coli M15 
(Qiagen, Valencia, CA, USA) was used for the expression of the treponeme Tp92 
homologs. E. coli containing the plasmids was cultured aerobically in Luria-
Bertani (LB) broth supplemented with 50 μg/ml of ampicillin for the DH5α-T1 or 
with 100 μg/ml of ampicillin and 25 μg/ml of kanamycin for the M15 strain. 
 
2.3. Cell culture and treatment  
To identify the expression of proinflammatory cytokines by Tp92 homologs, 
THP-1 cells (ATCC TIB-202), a human monocytic cell line and primary cultured 
periodontal ligament (PDL) cells were prepared as described previously [43]. THP-
1 and PDL cells were cultured in RPMI 1640 and α-minimal essential medium (α-
MEM) supplemented with 10% fetal bovine serum (FBS), respectively, and used 
for stimulation with the recombinant Tp92 homologs. KB cells (ATCC CCL-17), a 
carcinoma epithelial cell line, were cultured in RPMI 1640 medium supplemented 
with 10% FBS and used for a bacterial binding assay. Human monocytic THP-1 
cells (1 x 106 cells/ml) and primary cultured PDL cells (5 x 105 cells/ml) were 
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cultured as described above and plated in 35-mm culture dishes in the absence of 
serum. The cells were then treated with 10 μg/ml of each of the recombinant Tp92 
homologs for 8-24 h. The cells were harvested and used for RNA isolation, and the 
conditioned supernatants were collected and stored at -70°C for the gelatin 
zymography and ELISA. An NF-κB reporter cell line, CHO/CD14/TLR4, which 
expresses CD14 and TLR4 and has the CD25 reporter gene with the human E-
selectin promoter, was kindly provided by Dr. Han (School of Dentistry, Seoul 
National University, Seoul) and cultured as described previously [44]. The 
CHO/CD14/TLR4 cells were cultured in Hams-F12 medium (Hyclone 
Laboratories, Loan, UT, USA) supplemented with 10% FBS and were used to 
verify that prepared recombinant proteins were endotoxin free by flow cytometry 
analysis after treatment with the recombinant protein of the Tp92 homologs.  
To study stimulation of Td92 in the system for the inflammasome activation, 
THP-1 cells and human PBMC-derived monocytes that were differentiated into 
macrophages were used. For the experiments, THP-1 cells (2 x 106/well in 6-well 
plates) were differentiated into macrophage-like cells with 0.5 μM PMA for 3 h. 
Human monocytes were purified using Ficoll-Paque PLUSTM and were 
differentiated for 6 days in RPMI 1640 with 10% FBS. The cells were detached 
using 0.25% trypsin/EDTA and were seeded at 2 x 106/well in 6-well plates in 
RPMI 1640 with 10% human AB serum. The differentiated cells were treated with 
Tp92 homologs, live whole T. denticola cells, truncated Td92 polypeptides (Td-G 
and Td-B), MDP, fibronectin, GRGDSP peptide, GRADSP peptide, PP4, or LPS in 
serum-free medium for 1-6 h. In some experiments, the cells were pretreated with 
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NAC, PDTC, Apocynin, DPI, cytochalasin D, oxATP, Ac-YVAD-cho, Z-YVAD-
fmk, KCl, glybenclamide, tolbutamide, SB202190, SB203580, TPCK, BAY-
117082, SP600125, PD98059, an anti-human integrin α5β1 Ab, an anti-human 
fibronectin Ab, or an anti-human integrin ανβ3 Ab at the indicated concentrations 
for 30 min or 1 h before stimulation with the various stimuli for 6 h. MDP- or LPS-
stimulated cells were further incubated with 2.5 mM ATP for 30 min. Procaspase-1 
and proIL-1β in the cell extracts and the active forms secreted in the culture 
supernatant precipitated by 10% TCA were analyzed by immunoblotting. For the 
detection of NLRP3 expression, the cell lysates and culture supernatants were 
combined and used for immunoblotting.  
 
2.4. Sequencing of tp92 homologs  
The tp92 homolog of T. denticola (ATCC 35405, TDE2601 ORF, 46) was 
identified in the genome sequence of the bacterium using the NCBI BLAST 
program with the T. pallidum subsp. pallidum tp92 sequence. Nucleotide sequences 
of the tp92 gene and the T. denticola tp92 homolog were aligned using the program 
Align from EMBL-EBI, and several degenerate primers were designed for the 
initial amplification of the tp92 homologs of T. maltophilum and T. socranskii by 
PCR. In the case of T. lecithinolyticum, a portion of the tp92 homolog (400 bp) was 
originally identified by screening an expression library of this organism with 
antibodies directed against the T. lecithinolyticum outer membrane fraction. The 
full sequences of the tp92 homologs of T. lecithinolyticum, T. maltophilum and T. 
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socranskii were obtained by PCR amplification using the degenerate primers 
described above or by inverse PCR with specific primers designed from the partial 
sequence, followed by sequencing using a DNA sequencer (ABI, Applied 
Biosystems, CA, USA). 
Primary structure analysis of translated proteins was performed by using 
ProtParam from ExPASy. Pairwise sequence comparisons were performed using 
Align from EMBL-EBI to analyze sequence homology. Prediction of protein 
subcellular localizations and signal peptides were analyzed using PSORTb (version 
2.0, 20) and SignalP (version 3.0, 6), respectively.  
 
2.5. Cloning and expression of tp92 homologs, Td-G, and Td-B domain 
The tp92 gene homologs of T. denticola, T. lecithinolyticum, T. maltophilum, 
and T. socranskii were amplified from the genomic DNA by PCR and cloned 
without the sequences encoding their leader peptides. The sequences of the PCR 
primers were as follows: 5'-AAC TGA GCT CGG ATG GTA TAA TGG AAA 
ACC TG-3' (SacI-tagged) and 5'-AAC TCT GCA GCT ATA AAT TGG GTA 
TAT TGA ATG AA-3' (PstI tagged) for T. denticola; AAC TGA GCT CGA AAG 
CGA TTG GTA TTA CGG A (SacI-tagged) and AAC TCT GC A GTT ATT GAT 
TGG TAA GGT TAA AAG (Pst1-tagged) for T. lecithinolyticum; AAC TGG ATC 
CCA AAG CGA CAA TAA CTG GTA (BamH1-tagged) and AAC TGA GCT 
CTT ATT GAT TGA CCA AAT TG (Sac1-tagged) for T. maltophilum; AAC TGG 
13 
 
ATC CGA AGA AAG CGA AGA CGA AGG (BamH1-tagged) and AAC TAA 
GCT TTT ATC AGC GGT TCG TTA TGT TGA (HindIII-tagged) for T. 
socranskii. Tp92 homologs of oral spirochetes had predicted signal peptides (20-31 
amino acids) and molecular masses of 88-92-kDa for mature proteins. The Tp92 
homologs were named Td92 for T. denticola, Tl88 for T. lecithinolyticum, Tm88 
for T. maltophilum, and Tss88 for T. socrnaskii subsp. socranskii according to their 
molecular weights.  
To produce truncated Td92 polypeptides, Td92 gene fragments were divided 
into two fragments (the G-domain, which corresponded to the amino acid positions 
1-400 and the B-domain, which corresponded to the amino acid positions 401-798) 
according to the structural protein analysis using MODELLER. The fragments 
were amplified from the genomic DNA of T. denticola by PCR and cloned in E. 
coli using the expression vector pQE-30 for recombinant Td92 preparation. The 
primers used for PCR to amplify the G- and B-domain gene fragments were as 
follows: for the G-domain: 5'-AAC TGA GCT CGG ATG GTA TAA TGG AAA 
ACC TG-3'(SacI-tagged) and 5'- AAC TCT GCA GAT CAG GTT CCG AAC 
CCT GT-3'(Pst1-tagged); for the B domain: 5'-AAC T GA GCT CCT TGT GGA 
TAT TGT CAT CAA TG-3'(SacI-tagged) and 5'-AAC TCT GCA G CT ATA AAT 
TGG GTA TAT TGA ATG AA-3'(Pst1-tagged). The underlined sequences are the 
introduced recognition sites. Four nucleotides were added to the 5' ends of these 
restriction sites. The molecular masses of the recombinant G-domain (Td-G) and 
B-domain (Td-B) proteins were 46- and 45.5-kDa, respectively. PCR was 
performed in a total volume of 50 ml containing 15 pmol of each primer, 1.25 U of 
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ExTaq polymerase (Takara Bio, Otsu, Japan), and 100 pmol of dNTPs in a thermal 
cycler (MJ Research, Walham, MA, USA). The thermal cycle chosen included an 
initial denaturation step at 94°C for 4 min, 30 cycles of a denaturation step at 94°C 
for 1 min, an annealing step at 62°C for 1 min, and an extension step at 72°C for 1 
min, with a final incubation at 72°C for 5 min. The PCR products were cloned in E. 
coli using the TA cloning vector pCR2.1-TOPO and TA cloning kit (Invitrogen, 
Carlsbad, CA, USA). The plasmid DNA was isolated and digested with each of the 
above restriction enzymes. The fragments of each gene were cut out from agarose 
gel after electrophoresis and purified with a gel extraction kit (QIAGEN, Valencia, 
CA, USA). The purified gene was then ligated into the predigested pQE30 
expression vector using T4 DNA ligase (Boeringer Mannhein, Germany) at 16°C 
for 16 h as described previously [15]. E. coli M15 was transformed with the 
recombinant plasmids, plated on LB agar plates containing 100 μg/ml of ampicillin 
and 25 μg/ml of kanamycin, and grown overnight. Single recombinant colonies 
were grown in LB broth containing antibiotics until optical density (O.D) at 600 
nm is 0.60, the expression of recombinant proteins were induced with 1 mM 
isopropyl-b-D-thiogalactopyranoside (IPTG) for 4 h. The proteins were detected by 
immunoblotting by using polyclonal antibodies directed against penta-histidine 
(QIAGEN, Valencia, CA, USA). After confirmation of each protein expression, 50 
ml overnight cultures of E. coli transformed with each genes construct were 
inoculated into 500 ml of fresh LB broth and cultured until the optical density 
(O.D) at 600 nm is 0.60. After 1 mM IPTG was added, the cultures were incubated 
for an additional 4 h. The recombinant proteins formed in the inclusion bodies were 
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purified as follows. The bacteria harvested by centrifugation at 6,500 x g for 15 
min at 4°C and resuspended in 50 ml of IB washing buffer (20 mM Tris-HCl pH 
7.5, 10 mM EDTA, and 1% Triton X-100). The cells were lysed by incubating 
them with 100 μg/ml of lysozyme at 4°C for 15 min and subsequently sonicating 
them with an ultrasonic processor (10 sec bursts at output 20 W with a 10 sec 
cooling period between burst; Sonics&Materials, Inc. Newtown, Conn., USA). In 
order to minimize protein degradation, phenylmethylsulfonyl fluoride (PMSF; 1 
mM) was added to the bacterial lysates, and the inclusion bodies obtained by 
centrifugation at 10,000 x g for 10 min. The pellets were resuspended in 50 ml of 
the IB washing buffer and then centrifuged. This procedure was repeated 5 times. 
The inclusion bodies were resuspended in solubilization buffer (50 mM 3-
cyclohexylamino-1-propansulfonic acid (CHAPS pH 11.0), 1 mM DTT and 0.3% 
N-laurylsarcosine) and incubated at RT for 15 min. The suspension was then 
centrifuged at 10,000 x g for 10 min, and the supernatants containing the 
solubilized proteins were collected and dialyzed against 100 volumes of 20 mM 
Tris-HCl (pH 8.5) for 24 h with three times changes. The recombinant proteins 
were purified by using nickel-nitrilotriacetic acid agarose (Ni-NTA agarose; 
QIAGEN, Valencia, CA), which bound to the histidine-tagged recombinant 
proteins, according to the manufacturer’s protocol with a few modification. Briefly, 
the recombinant proteins binding to Ni-NTA agarose was washed 5 times with 10 
ml of wash buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8.0). 
Endotoxins present in E. coli, which could potentially contaminate the recombinant 
proteins, were removed using polymyxin B-agarose, according to the 
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manufacturer’s instructions (Sigma Chemical Co., St. Louis, MO, USA). The 
purified recombinant proteins were dialyzed against 200 volumes of PBS with 
three buffer changes for 24 h. The recombinant proteins were concentrated using 
Centricon YM-30 (Millipore, Bedford, MA), then were filtrated through 
polyvinylidene fluoride (PVDF; Millipore, Bedford, MA) membrane with 0.22 μm 
pore-size. The identities of purified proteins were confirmed by SDS-PAGE and 
immunoblotting. For the mock control, an irrelevant recombinant peptide, PP4, was 
also prepared using the same procedures. PP4 is a C-terminal partial peptide (187 
amino acid residues, molecular mass of 20.2 kDa) of the Treponema 
lecithinolyticum surface protein MspTL (570 amino acid residues) and does not 
have cell-stimulating activity [45]. 
 
2.6. Verification of endotoxin decontamination in the recombinant 
proteins 
The most critical point in this study was to minimize endotoxin contamination 
of recombinant Tp92 homologs. To confirm that its activity was not a result of E. 
coli endotoxin contamination, the procedures were re-examined as follows: First, 
TLR4-dependent NF-κB activation was analyzed to verify endotoxin 
decontamination in the recombinant Tp92 homologs by flow cytometric analysis. 
CHO/CD14/TLR4 cells were cultured to 70% confluency in Hams-F12 media and 
stimulated with the recombinant Tp92 homologs (10 μg/ml) or LPS (1 μg/ml) for 
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16 h in the presence of 2% FBS. The cells were subjected to flow cytometric 
analysis using fluorescein isothiocyanate (FITC)-labeled mouse anti-human CD25 
(Becton Dickinson, San Diego, CA) as described previously [44]. FITC-labeled 
mouse IgG1 (Becton Dickinson) was used as an isotype matched control. Second, 
the actual endotoxin activity of recombinant Tp92 homologs was measured by the 
Limulus amoebocyte lysate (LAL) assay using an LAL Endochrome Kit (Charles 
River Endosafe, Wilmington, MA, USA) according to the manufacturer’s protocol. 
In principle, endotoxin activated a proenzyme in LAL. In the presence of a 
colorless substrate, the activated enzyme rapidly catalyzed the cleavage of the 
chromophore p-nitroaniline, which produced a yellow color and the color was 
measured at 405 nm. A standard curve was run with E. coli control standard 
endotoxin from the kit. The final preparation of recombinant Td92, Tl88, Tm88, 
Tss88, Td-G, and Td-B contained 0.37, 0.23, 0.21, 0.10, 0.21, and 0.20 endotoxin 
Unit (EU)/μg of the protein, respectively. Third, recombinant Td92 after 1% Triton 
X-114 extraction was evaluated. The Triton X-114 two-phase extraction method is 
an efficient method to dissociate endotoxin from biomolecules including 
recombinant proteins [46]. After phase separation, endotoxin is found in the 
detergent phase, and the desired biomolecule is found in the upper aqueous phase. 
Td92 and E. coli LPS were re-extracted three times with Triton X-114 (at a final 
concentration of 1%), and the resulting upper aqueous phase was used for cell 
treatment. Lastly, to exclude the possibility that proIL-1β mRNA upregulation by 
Td92 is the result of contaminants LPS signaling, experiments were performed 
with siRNA against TLR4, MyD88 and TRIF. 
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2.7. Production of antiserum against the Tp92 homolog of T. denticola  
Polyclonal antibodies against T. denticola Tp92 homolog were raised in New 
Zealand White rabbits by intradermal administration of 500 μg of the purified 
proteins with Complete Freund’s Adjuvant (500 μg, F5881, Sigma) followed by 
three subsequent boosts of 200 μg of the protein with Incomplete Freund’s 
Adjuvant (500 μg, F5506, Sigma) in two-week intervals. Antiserum was collected 
one week after the final boost. The antiserum was shown to contain high titers of 
specific antibodies against the recombinant T. denticola Td92, as judged by ELISA 
and immunoblot using horseradish peroxidase (HRP)-labeled mouse anti-rabbit 
IgG (R&D Systems, Minneapolis, MN, USA). Antibodies which cross-reacted with 
E. coli proteins and the histidine-tag, were removed by using affinity 
chromatography with activated Cyanogen-bromide (CNBr)-activated Sepharose 4B 
(Amersham Pharmacia Biotech, Piscataway, NJ, USA) according to standard 
protocols. For this purpose, E. coli M15 sonicates or an irrelevant histidine tagged 
protein, PP4 [45] were coupled to CNBr-activated Sepharose 4B. The antiserum 
was applied to the Sepharose and the unbound fraction of the antiserum containing 
the specific Ab was collected. IgG antibodies (designated as a Td92 Ab) were 
purified using an ImmunoPure (A Plus) IgG purification kit according to the 
manufacturer’s instructions (Pierce, Rockford, IL, USA). Finally, endotoxin 
contamination in the IgG fraction was removed using polymyxin-B agarose (Sigma 




2.8. Preparation of outer membrane of T. denticola  
To evaluate the actual surface location of T. denticola Td92, the outer 
membrane (OM) of T. denticola was isolated by a combined protocol of freeze-
thaw procedures and sucrose density gradient centrifugation with a slight 
modification [47, 48]. Briefly, T. denticola cells (80 ml culture) were harvested and 
washed with PBS by centrifugation at 8,000 x g for 10 min. The cell pellet was 
resuspended in 1 ml of 50 mM Tris-HCl buffer (pH 7.2) containing 20 mM MgCl2, 
2 mM PMSF and DNase1 (4 U/ml). After the cells were subjected to 40 freeze-
thaw cycles, the disrupted cell suspension was centrifuged at 8,000 x g for 10 min. 
The supernatant containing the OM was transferred to a new tube and centrifuged 
at 25,000 x g for 30 min. The pellet was washed twice with 50 mM Tris-HCl (pH 
7.2), resuspended in 1 ml of 0.1 M sodium acetate buffer (pH 3.0), and mixed 
gently for 2 h to remove contaminating flagella followed by centrifugation at 
25,000 x g for 30 min. The pellet was washed with and resuspended in 0.8 ml of 50 
mM Tris-HCl buffer and subjected to sucrose gradient centrifugation consisting of 
25, 42 and 56% sucrose at 100,000 x g for 16 h at 4℃ by an ultracentrifuge 
(Beckman TLA110 rotor, Beckman Instruments Inc., Fullerton, CA). The upper 
fraction containing the OM was removed and precipitated with methanol and 
chloroform. The OM precipitated was resuspended in 50 µl of PBS and used to 
detect Td92 by SDS-PAGE and immunoblot analysis. 
To test whether the native protein functions similarly to the recombinant 
protein, native Td92 was isolated from T. denticola as follows. The protein was 
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kindly provided by Dr. Lee (School of Dentistry, Dankook University, Cheonan). 
Protein G-coated agarose beads (2 ml, 1 mg/ml) were incubated with 5 ml of rabbit 
anti-Td92 IgG (4 mg/ml) at 4°C for 12 h. The beads were washed three times with 
binding buffer (0.1 M phosphate, 0.15 M NaCl, pH 7.2) and were incubated with 
0.5 mM disuccinimidyl suberate on a rotator for 1 h at room temperature. The 
beads were washed three times with 0.2 M glycine (pH 2.5) and were placed in 
PBS (pH 7.2) for 4 h at 4°C. Anti-Td92 IgG-bound beads were then incubated with 
the whole lysates of T. denticola from which proteins smaller than 50 kDa were 
removed using an Amicon Ultra centrifugal filter (Millipore, Bedford, MA). The 
beads were washed three times with PBS including 0.02% Tween 20. Native Td92 
was eluted with 0.2 M glycine (pH 2.5) and was immediately neutralized with 
phosphate buffer (1 M phosphate, 0.15 M NaCl, pH 7.5). Finally, native Td92 was 
dialyzed three times at 4°C for 12 h in PBS, and the protein was confirmed by 
immunoblotting using the Td92 Ab along with recombinant Td92. Endotoxin 
contamination of native Td92 was undetectable by the LAL assay. 
 
2.9. Immunoblotting 
To verify the expression of the Tp92 homologs in E. coli, E. coli M15 cells 
transformed with the recombinant plasmids were cultured in LB broth containing 
antibiotics and induced with IPTG. The E. coli lysates (50 μg of protein) were 
subjected to SDS-PAGE and subsequently transferred to nitrocellulose membranes. 
The membranes were blocked with 2% BSA for 1 h and reacted with anti-mouse 
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histidine Ab for 1 h. After washing with PBS-0.2% Tween 20, the membranes were 
reacted with alkaline phosphatase (AP)-labeled anti-mouse IgG for 1 h. After 
washing with PBS-0.2% Tween 20, the membranes were developed with 5-bromo-
4-chloro-3-indolylphosphate (165 μg/ml) and nitroblue tetrazolium (330 μg/ml).  
To test the reactivity of the Td92 Ab in the lysates of T. denticola whole cells, 
the OM fraction, and the recombinant Td92, whole cell lysates of T. denticola, the 
OM, and Td92 were separated by SDS-PAGE and transferred to nitrocellulose 
membranes. The membranes were blocked with PBS-2% BSA, reacted with a 
Td92 Ab for 1 h, followed by HRP-labeled mouse anti-rabbit IgG for 1 h. After 
washing with PBS-0.2% Tween 20, the membranes were developed with 3, 3′, 5, 
5′-tetramethylbenzidine (TMB, Sigma). To verify the purity of the OM preparation, 
the immunoblot was performed using a FlaA (1:5000 dilution, a kind gift from Dr. 
Christopher Fenno (School of Dentistry, University of Michigan, USA) which 
detects the periplasmic protein FlaA of T. denticola.  
To detect various host factors, the cells were treated with the different stimuli. 
After washing with chilled PBS, the cells were lysed in 50 µl of RIPA buffer (10 
mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 50 mM NaF, 1 mM 
EDTA, 5 µM Na3VO4, and 1 mM PMSF). The lysates were clarified by 
centrifugation at 13,000 x g for 45 min at 4°C. The protein concentration was 
determined using a bicinchoninic acid (BCA) protein assay Kit. Cell lysates and 
TCA-precipitated supernatants were separated by SDS-PAGE (using a 12% gel) 
and were transferred onto PVDF membranes. The membranes were incubated with 
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a specific antibody followed by a horseradish peroxidase-conjugated secondary 
antibody. Immunoreactive proteins were developed using a standard ECL reaction 
(Amersham/Pharmacia Biotech, Piscataway, NJ) according to the manufacturer’s 
instructions. β-Actin was used as a loading control. The band intensities were 
quantified using the NIH Image J software, and the specific band intensity was 
normalized to β-Actin. 
 
2.10. Immunodot blotting 
The cross-reactivity of Tp92 homologs with a Td92 Ab was analyzed by 
immunodot blotting. The recombinant Tp92 homologs (250 ng in 1 μl) were 
applied onto a nitrocellulose membrane and air dried. The membranes were 
blocked with PBS-2% BSA, reacted with a Td92 Ab for 1 h, followed by HRP-
labeled mouse anti-rabbit IgG for 1 h. After washing with PBS-0.2% Tween 20, the 
membranes were developed with 3, 3′, 5, 5′-tetramethylbenzidine (TMB, Sigma). 
An irrelevant histidine-tagged recombinant protein, MspTL [45] and E. coli lysates 
were used as negative controls. 
 
2.11. Indirect immunofluorescence microscopy 
Treponema species grown to an early stationary phase were harvested, 
resuspended in PBS, and applied to glass slides coated with silane (Sigma). Some 
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of the slides were used directly and the others were used after fixation with cold 
acetone for 15 min and subsequent permeabilization of the outer membrane with 
0.1% Triton X-100 in PBS for 5 min. The bacteria were incubated in PBS 
containing 1% BSA in for 1 h and then reacted with a Td92 Ab or a FlaA Ab 
(1:1000 dilution) for 1 h. After washing three times with PBS, the bacteria were 
subsequently reacted with FITC-labeled goat anti-rabbit IgG (1:50 dilution in PBS 
containing 1% BSA) and washed three times with PBS. To see all the bacteria 
applied, the slides were further stained with a fluorescent nucleic acid stain, 
Hoechst dye 33342 (2 μg/ml in PBS, Invitrogen), for 30 min. The cells were 
washed three times with PBS and observed with a fluorescence microscope (Carl 
ZEISS, Axioskop, Germany) at 1000 x magnification. The FlaA Ab (1:500 
dilution) was used as a control to verify that the outer membrane of the bacteria 
was intact during immunofluorescence assay. As a control for nonspecific binding, 
isotype-matched Ab (rabbit IgG) was used instead of the Td92 Ab. 
To analyze ability of intact bacteria to react with the Td92 Ab, T. denticola 
cells (5 x 107) were fixed with acetone and permeabilized as described above. Non-
fixed and acetone-fixed bacteria were reacted with the Td92 Ab or the FlaA Ab (1: 
500 dilution) in 100 μl of PBS containing 1% BSA at room temperature for 1 h. 
The bacteria were washed twice with PBS containing 0.02% BSA and reacted with 
FITC-labeled goat anti-rabbit IgG (1:50 dilution in 1% BSA in PBS) at room 
temperature for 1 h. After washing twice with PBS, the bacteria were analyzed 
using a fluorescence-activated cell sorter (FACSCalibur; Becton Dickinson, San 
Jose, CA). The data were obtained by using 40,000 cells. The number of bacteria 
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was enumerated as described previously [49]. Isotype matched Ab (rabbit IgG) was 
used as a negative control. 
 
2.12. Immunogold staining of T. denticola 
T. denticola cells (OD 600 = 0.2; corresponded to 5 × 109cells/ml) were 
incubated with 200 µl of blocking solution (PBS containing 1% BSA) for 1 h. The 
bacteria were then incubated with 100 µl of the Td92 Ab (1: 50 dilution in PBS 
containing 1% BSA) or isotype-matched Ab (rabbit IgG) for 1 h. After washing 
three times with PBS, the bacteria were reacted with anti-rabbit IgG conjugated 
with 10-nm colloidal gold particles (1:50 dilution in PBS containing 1% BSA; 
Sigma) for 1 h. After washing three times with PBS, the bacteria were resuspended 
in PBS and absorbed onto formvar/carbon-coated 400-mesh copper grids. After 
washing with PBS and air drying, the bacteria were negative stained with 1% 
uranyl acetate for 15 s. After washing with PBS and air drying, the bacteria were 
observed with a transmission electron microscopy (JEOL, JEM-1200EX, Japan) at 







2.13. Fluorescence labeling of protein and bacteria  
In order to analyze the binding and the internalization of the Tp92 homologs 
into the host cells and immobilized fibronectin, Tp92 homologs and fibronectin 
were fluorescence labeled using DyLight 488 NHS Ester according to the 
manufacturer’s protocol (Pierce, Rockford). Calculated amount (mg) of DyLight 
NHS Ester fluor was added to Tp92 homologs (1 mg/ml) solution and incubated at 
room temperature for 1 h. To remove non-reacted reagent from the proteins, the 
proteins were dialyzed against 200 volumes of labeling buffer (0.05 M sodium 
borate buffer, pH 8.5) with three buffer changes at 4°C for 24 h.  
To label bacteria, T. denticola was grown to an early stationary phase, 
harvested, resuspended in PBS, and adjusted to have an OD600 = 1.0. Aliquots (1 
ml) of bacteria were centrifuged and resuspended in 1 ml PBS. The bacteria were 
stained with 10 μM carboxyfluorescein diacetate, succinimidyl ester (CFSE, 
Molecular Probes, Eugene, OR) for 10 min at room temperature and washed three 
times with PBS, followed by storage at -20°C for 24 h to induce fluorescence 
stabilization. CFSE-labeled bacteria were diluted with PBS to an OD600=0.2 (5 x 
109 bacteria/ml). 
 
2.14. Cell binding and internalization assay  
To determine whether the Tp92 homologs were able to bind to host cells, the 
binding assay was performed using KB cells, a carcinoma epithelial cell line, and 
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FITC-labeled Tp92 homologs. KB cells (1 x 105 cells/500 μl) were cultured in 24-
well culture plates to confluence. After changing to serum-free medium, the FITC-
labeled Tp92 homologs were added to the cells (at 2.5 μg per well) and incubated 
at 37°C under 5% CO2 for 1 h. The cells were detached from the cell culture plates 
using 200 μl of 1 x trypsin-EDTA, and washed with serum containing medium and 
subsequently with PBS three times by centrifuging at 100 x g. The fluorescence of 
the cells was then measured by a fluorometer (FLUOStar+ OPTIMA, BMG 
Labtechnologies Inc., Durham, NC). Protein binding was expressed as a percentage 
of total proteins added using formula as follows: bound fluorescence/total 
fluorescence added x 100. One microgram of Td92 was equivalent to 1 x 109 cells 
of T. denticola, as judged by SDS-PAGE and subsequently by immunoblotting of 
aliquots containing various numbers of bacteria. The number of T. denticola 
(OD600=0.2) corresponded to 5 x 109 cells/ml, when determined using a Petroff-
Hausser counting chamber (Hausser Scientific, Hosham, PA).  
To confirm that the Tp92 homologs function as adhesins, binding inhibition of 
fluorescence-labeled T. denticola to epithelial cells by Td92 was tested. KB cells 
were cultured in 24-well culture plates (1 x 105 cells/500 μl) to confluence, washed 
twice with serum-free medium, and incubated with CFSE-labeled bacteria (100 μl 
of OD600=0.2, 5 x 108 bacteria) in the presence of Td92 (1 to 10 μg) at 37°C under 
5% CO2 for 1 h. The cells were detached and washed three times with PBS by 
centrifuging at 100 x g, and the fluorescence of the adherent bacteria was 
determined using a fluorometer as described above. An irrelevant histidine-tagged 
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recombinant protein (PP4) was used as a negative control. The ratio of T. denticola 
to KB cells used for the binding competition assay was 5,000:1.  
To analyze the effect of inhibitory antibodies, cytochalasin D, and Profect P1 
on FITC-labeled Td92 binding and internalization into the cells, PMA-
differentiated THP-1 cells were seeded at 2 x 105 cells/500 μl in 24-well culture 
plates and were reacted with 150 μl of integrin α5β1 Ab (10 and 20 μg/ml), an anti-
mouse IgG (10 μg/ml), or cytochalasin D (1 and 2.5 μM) for 30 min or 1 h. The 
cells were subsequently treated with FITC-labeled Td92 (10 μg/ml) and were 
incubated at 37°C for additional 30 min to 1 h. After washing the cells with PBS, 
the binding of Td92 was analyzed by flow cytometry (FACSCalibur, BD, San Jose, 
CA, USA). To test of the efficiency of Profect P1 for protein transfection, the cells 
were treated with pre-incubated mixture of FITC-Td92 (5 μg)-Profect P1 (2.5 μl) 
for 1 and 4 h and were analyzed by flow cytometry. FITC-Td92-treated cells that 
had been fixed in 2% paraformaldehyde were used as a negative control for 
internalization. Trypan blue (4%) was used to quench cell-bound fluorescence and 
to detect intracellular fluorescence exclusively. 
 
2.15. Real-time qPCR  
RNA from the THP-1 cells, PDL cells, and PMA-differentiated THP-1 cells 
treated with the Tp92 homologs was prepared using an easy-BLUE total extraction 
kit (iNtRON Biotechnology, Korea) and cDNA was synthesized from 1 μg of RNA 
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using a Maxime RT PreMix kit (iNtRON Biotechnology, Korea) according to the 
manufacturer’s protocols. For real-time qPCR, cDNA (1 μl) was mixed with 10 μl 
of SYBR Premix Ex Taq (Takara Bio Inc. Japan) and primer pairs (4 pmol each) in 
a 20 μl reaction volume, followed by PCR for 40 cycles of a denaturation step at 
95°C for 15 sec, an annealing step at 60°C for 15 sec, and an extension step at 
72°C for 33 sec in an ABI PRISM 7500 Fast Real-Time PCR System (Applied 
Biosystems, Foster City, CA, USA). The PCR products were subjected to melting 
curve analysis to verify the presence of a single amplification product. PCR 
without RT was performed as a negative control. The housekeeping gene encoding 
glyceraldehyde dehydrogenase (GAPDH) was used as a reference in order to 
normalize expression levels and to quantify the changes in gene expression 
between non-stimulated cells and stimulated cells. The expression level of the gene 
was normalized against GAPDH and calculated by using the 2−ΔΔCT method [50]. In 
the expression of proinflammatory factors in Tp92 homologs-stimulating THP-1 
and PDL cells, the data shown fold change to control was expressed as a log2 ratio. 
The sequences of the primers for real-time qPCR were as follows: 5'-AGC TGT 
ACC CAG AGA GTC C-3' and 5'-ACC AAA TGT GGC CGT GGT TT-3' for IL-
1β; 5'-AAC CTG TCC ACT GGG CAC A-3' and 5'-TCT GGC TCT GAA ACA 
AAG GAT-3' for IL-6; 5'-GTG AAG GTG CAG TTT TGC CA-3' and 5'-TCT 
CCA CAA CCC TCT GCA C-3' for IL-8; 5'-CAG GGA CCT CTC TCT AAT CA-
3' and 5'-AGC TGG TTA TCT CTC AGC TC-3' for TNF-α; 5'-CTC TGG AGG 
TTC GAC GTG A-3' and 5'-CTG CAG GAT GTC ATA GGT CA-3' for MMP-9; 
5'-AAG CTG GGA AGC CTT CTC TA-3' and 5'-GTG CTG GGC AAA GAA 
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TGC AA-3' for COX-2; 5'-TGA AGA GGA GTG GAT GGG TT-3' and 5'-TTC 
AAT GCA CTG GAA TCT GC-3' for NLRP3; 5'-GAT GCG GAA GCT CTT 
CAG TT-3' and 5'-AGG ATG ATT TGG TGG GAT TG-3' for ASC; 5'-CAG AAC 
CCT GCT GAC TGA GA-3' and 5'- CCA AAT GGA AAG GTC AAA GG-3' for 
NLRC4; 5'-CCA AGG GGA ATC AGA ACT CA-3' and 5'-TGG AGC AGG CCC 
AAA TAT AG-3' for integrin α5; 5'-GTG GTG GAC CTG ACC TGC-3' and 5'-
TGA GCT TGA CAA AGT GGT CG -3' for GAPDH.  
 
2.16. Gelatin zymography  
To detect MMP-9 expression, gelatin zymography with culture supernatants 
(25 ml) of THP-1 cells treated with the Td92 homologs was performed as described 
previously [43]. Culture supernatants of THP-1 cells treated with 10 μg of E. coli 
LPS were used as positive controls. Culture supernatants of nontreated cells or 
mock extract-treated cells were used as a negative control.  
 
2.17. Determination of ROS level 
THP-1 cells (2 x 105/ml) were seeded at a 96 well culture plates and 
differentiated into macrophages by culturing with 160 nM PMA for 72 h, replacing 
the medium without PMA for 24 h. The cells were switched to serum-free media 
for 16 h and removed media, and incubated with 10 µM DCF-DA for 30 min at 
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37℃. The cells then washed with serum-free media, followed by exposure to Td92 
(10 μg/ml), LPS (10 μg/ml), or 100 µM H2O2 in serum-free media. ROS generation 
of cells was observed using excitation at 485 nm and emission at 520 nm using 
FLUO Star OPTIMA (BMG Labtechnologies, Inc. Durham, NC). 
 
2.18. Determination of extracellular ATP level  
PMA-differentiated THP-1 cells (2 x 106/ml in 6-well plates) were stimulated 
with Td92, T. denticola, fibronectin, GRGDSP peptide, GRADSP peptide 
(negative control for the RGD peptide), or PP4 for 2 h. The extracellular ATP level 
was determined using an ATP bioluminescence assay Kit (Roche, Mannheim, 
Germany) according to the manufacturer’s protocol. Briefly, the culture 
supernatants were mixed with 0.3% TCA and were kept at 4°C for 30 min. After 
adding four volumes of 250 mM Tris acetate (pH 7.75), the mixture was mixed 
with the ATP assay reagents as described previously [51]. The luminescence was 
measured using a ModulusTM Microplate Luminometer (Promega, Madison, WI, 
USA). In some experiments, the cells were pretreated with the integrin α5β1 Ab for 






2.19. RNA interference assay  
The siRNA duplex was designed by the Invitrogen Block-iT RNAi Designer 
program. The gene accession numbers are NM-001079821 (NLRP3), NM-013258 
(ASC), NM-021209 (NLRC4), NM-138554 (TLR4), NM-002468 (MyD88), NM-
182919 (TRIF), and NM-002205 (integrin α5). The sequences were as follows: 5'-
AUC ACA GUG GGA UUC GAA ACA CGU G-3' and 5'-CAC GUG UUU CGA 
AUC CCA CUG UGA U-3' for siNLRP3 duplex; 5'-AAG AGC UUC CGC AUC 
UUG CUU GGG U-3' and 5'-ACC CAA GCA AGA UGC GGA AGC UCU U-3' 
for siASC duplex; 5'-UGC AGU UCG AAA UCA AAC UUG UGG G-3' and 5'-
CCC ACA AGU UUG AUU UCG AAC UGC-3' for siNLRC4 duplex; 5'-UAA 
GGU AGA GAG GUG GCU UAG GCU C-3' and 5'-GAG CCU AAG CCA CCU 
CUC UAC CUU A-3' for siTLR4 duplex; 5'-AUU CCU UGC UCUGCA GGU 
AAU CAU C-3' and 5'-GAU GAU UAC CUG CAG AGC AAG GAA U-3' for 
siMyD88 duplex; 5'-UAC AAG AGC UUG UCC UGG CCU GCU G-3' and 5'-
CAG CAG GCC AGG ACA AGC UCU UGU A-3' for siTRIF duplex; 5'-UGG 
CCA UGA UGA GUU UGG CCG AUU U-3' and 5'-AAA UCG GCC AAA CUC 
AUC AUG GCC A-3' for integrin α5 siRNA duplex. Each of the specific siRNAs 
and siRNA negative controls were resuspended to a final concentration of 10 µM, 
and Lipofectamine RNAiMAX diluted in 250 µl of serum-free RPMI 1640 without 
antibiotics was mixed with an equal volume of diluted siRNA (10 to 30 nM). 
PMA-differentiated THP-1 cells (2 x 106 cells/well) in RPMI 1640 containing 10% 
FBS without antibiotics in 6-well plates were transfected with the 
RNAiMAX/siRNA mixtures. Following an 18- to 48-h incubation at 37°C (5% 
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CO2 atmosphere) and washing, the cells were treated with Td92 (10 μg/ml), MDP 
(10 μg/ml), E. coli DH5α RNA (5 μg/ml), S. typhimurium flagellin (500 ng/ml), or 
LPS (10 μg/ml) for 6 h as described above. MDP- and LPS-stimulated cells (for 
TLR4 knockdown experiments) were subsequently pulsed with 2.5 mM ATP for 
30 min. To assess cell viability following siRNA transfection, THP-1 cells were 
stained with Hoechst 33342 after transfection with nonsilencing siRNA using the 
Lipofectamine RNAiMAX Reagent. The cells appeared healthy and viable after 
transfection. The knockdown of each gene and protein was analyzed by real-time 
qPCR and immunoblotting, respectively. The levels of procaspase-1 and proIL-1β 
in the cell extracts and of their active forms secreted in the supernatant precipitated 
by 10% TCA were analyzed by immunoblotting. 
 
2.20. Protein transfection  
Td92 (10 µg) or flagellin (500 ng) was mixed with 2.5 µl Profect P1, a protein 
transfection reagent, in 100 µl of serum-free RPMI 1640 medium without 
antibiotics at room temperature for 20 min. PMA-differentiated THP-1 cells (2 x 
106 cells/ml in 6-well plates) were stimulated with the mixture for 3 and 6 h. The 





2.21. Determination of cell death 
Cell death was measured using the LDH release assay and propidium iodide 
(PI) uptake. PMA-differentiated THP-1 cells (5 x 104 cells/200 µl in a 96-well 
plates) were stimulated with Td92 (1 to 20 μg/ml), T. denticola (MOI of 100 and 
1000) or PP4 (10 μg/ml) for 1-40 h. In some experiments, the THP-1 cells were 
pretreated with KCl (30 to 70 mM), oxATP (300 µM), or the caspase-1 inhibitors 
Ac-YVAD-cho (1 to 50 µM) and z-YVAD-fmk (1 to 50 µM) prior to stimulation 
with 10 μg/ml of Td92 for 6 h. Release of cytoplasmic LDH into the supernatant 
was measured from triplicate samples using an LDH cytotoxicity assay Kit 
according to the manufacturer's instructions. Cytotoxicity was calculated using the 
equation 100 × (experimental LDH − spontaneous LDH)/ (maximum LDH release 
− spontaneous LDH). The maximum release of LDH was obtained by cell lysis 
with the detergent Triton X-100.  
Pore formation in THP-1 cells was determined by the quantification of PI 
uptake. PMA-differentiated THP-1 cells (2 x 105 cells/500 μl in 24-well plates) 
were treated as described for the LDH release assay. The cells were washed with 
PBS and were stained with PI (20 μM) and Hoechst 33342 (10 μM) for 30 min. 
After washing the cells with PBS, images were acquired using fluorescence 
microscopy (Nikon ECLIPSE TE 200, Tokyo, Japan). PI-positive cells were 
counted using NIH Image J software, and the pore-forming activity was expressed 
as the percentage of PI-positive cells in a total of 1000. At least five fields (x 400) 
were counted.   
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2.22. Ligand-binding assay 
PMA-differentiated THP-1 cells (8 x 106cells/5 ml in 100 mm dishes) were 
lysed with prechilled lysis buffer (25 mM HEPES, pH 7.5, 150 mM NaCl, 1% 
Nonidet P-40, 0.25% Na-deoxycholate, 10% glycerol, protease inhibitor cocktail). 
THP-1 cell lysates (1.4 mg in 100 μl) were reacted with Td92 (50 μg), Td92 
preincubated with fibronectin (50 μg Td92 + 50 μg fibronectin, 37°C for 1 h), or 
PP4 (50 μg) in a total reaction volume of 300 μl while slightly inverting at 4°C 
overnight. The reaction mixtures were then incubated with 30 μl of Ni-NTA 
agarose at 4°C for 4 h. To minimize the background, the reacted agarose was 
washed five times with washing buffer A (50 mM HEPES, pH 7.5, 300 mM NaCl, 
20 mM imidazol, 0.1 mM PMSF). Proteins bound to the agarose were eluted with 
elution buffer (Washing buffer A containing 250 mM imidazol). The eluted 
samples were boiled in 2 x SDS sample buffer and were used for SDS-PAGE 
followed by immunoblotting for the detection of integrin subunits (α5, αν, β1, and 
β3), fibronectin, Td92, and PP4 using an integrin α5 Ab, an integrin αv Ab, an 
integrin β1 Ab, an integrin β3 Ab, a fibronectin Ab, and a histidine Ab (for the 
detection of the recombinant Td92 and PP4), respectively.  
To analyze direct interaction of Td92 with integrin α5β1, the integrin α5β1 Ab 
(3 μg) or the integrin αvβ3 Ab (3 μg) as a control were incubated with 20 μl of 
Protein G-agarose (1 mg/ml) at 4°C for 4 h. After washing with washing buffer B 
(50 mM HEPES pH 7.5, 150 mM NaCl, 1 % Nonidet P40, 0.5% sodium 
deoxycolate, and 0.1 mM PMSF), the integrin α5β1 Ab bound to agarose was 
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reacted with recombinant human integrin α5β1 (10 μg), and the integrin αvβ3 Ab 
bound to agarose was reacted with recombinant human integrin αvβ3 (10 μg) at 
4°C overnight. After washing, the agarose was reacted with Td92 (10 μg), 
fibronectin (20 μg), or PP4 (10 μg) at 4°C overnight. After washing five times, the 
resultant agarose was boiled in 2 x SDS sample buffer and was used for SDS-
PAGE followed by immunoblotting with a histidine Ab, a fibronectin Ab, or an 
integrin α5 Ab. Control experiments were performed with Protein G-agarose in the 
absence of integrin α5β1 or integrin αvβ3. 
 
2.23. Detection of fibronectin in macrophages and monocytes  
PBMC-derived macrophages, PMA-differentiated THP-1 cells, or 
undifferentiated THP-1 cells were seeded at 2 x 106 cells/ml 6-well plates. After 6 
h incubation, the cells were washed with chilled PBS and were lysed in 50 µl of 
RIPA buffer (10 mM Tris-HC1, pH 7.5, 150 mM NaCl, 1% Triton X-100, 50 mM 
NaF, 1 mM EDTA, 5 µM Na3VO4, and 1 mM PMSF). The lysates were clarified 
by centrifugation at 13,000 x g for 45 min at 4°C. After precipitation of the 
proteins in the culture supernatants with 10% TCA, the cleared lysates and 





2.24. Endoglycosidase digestion and tunicamycin treatment of THP-1 
cells 
THP-1 cell lysates (10 μg or 20 μg) were boiled in 20 μl denaturing buffer 
(1% SDS, 1% 2-mercaptoethanol) at 100 °C for 2 min. After cooling, the lysates 
were incubated with 1 unit of N-glycosidase F in 0.5% Triton X-100 at 37°C for 2 
h. After heat-inactivated at 100 °C for 1min, the protein were boiled in SDS sample 
buffer, loaded on 8% SDS-PAGE gels, and then transferred onto a PVDF 
membrane. THP-1 cells (2 x 106 cells/ml in 6-well plates) were differentiated into 
macrophage-like cells in medium containing 10% FBS and 0.5 μM PMA in the 
presence of 1 μg/ml of tunicamycin which inhibits N-glycosylation of newly 
synthesized glycoproteins for 3 h. After washing, the cells were incubated in 
serum-free media in the presence of 1 μg/ml of tunicamycin for additional 6 h. 
Cells were harvested, rinsed with PBS, and lysed with prechilled lysis buffer (25 
mM HEPES, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.25% Na-deoxycholate, 
10% glycerol, protease inhibitor cocktail). The cell lysates (20 μg of protein) were 
subjected to immunoblotting to detect protein deglycosylation and integrin β1. For 
the glycoprotein detection (lectin blotting), proteins transferred to the PVDF 
membrane were incubated with 2 μg/ml of biotinylated Phaseolus vulgaris 
leucoagglutinin for 1 h after blocking with 1% BSA followed by incubation with 




To see the effect of deglycosylation of integrin on Td92 binding, THP-1 cell 
lysates (1.4 mg in 100 μl) treated with 1 μg/ml of tunicamycin were reacted with 
Td92 (50 μg) in a total reaction volume of 300 μl while slightly inverting at 4°C 
overnight. The reaction mixtures were then incubated with 30 μl of Ni-NTA 
agarose at 4°C for 4 h. To minimize the background, the reacted agarose was 
washed five times with washing buffer A (50 mM HEPES, pH 7.5, 300 mM NaCl, 
20 mM imidazol, 0.1 mM PMSF). Proteins bound to the agarose were eluted with 
elution buffer (washing buffer A containing 250 mM imidazol). The eluted samples 
were boiled in 2 x SDS sample buffer and were used for SDS-PAGE followed by 
immunoblotting for the detection of integrin subunits (α5, β1) and Td92 using an 
integrin α5 Ab, an integrin β1 Ab, and a histidine Ab (for the detection of the 
recombinant Td92), respectively.  
 
2.25. Blocking of Td92-induced signaling with the neutralizing integrin 
α5β1 Ab  
PMA-differentiated THP-1 cells (2 x 106 cells/ml in 6-well plates) were 
serum-starved in serum-free media for 24 h. The cells were pretreated with the 
human integrin α5β1 Ab or the anti-mouse IgG1 isotype control for 1 h before 
stimulation with Td92 for 30 min. The cell lysates were subjected to 
immunoblotting for the detection of p-p38, p-ERK (42/44 kDa), p-JNK (46/54 
kDa), IkB-α, and β-Actin using the corresponding antibodies. 
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2.26. Fibronectin binding assay  
To evaluate Td92 binding to soluble fibronectin, 96-well microtiter plates 
were coated with 100 μl of Td92 (10 μg/ml) or skim milk (5 μg/ml) as a 
nonspecific binding control at 4°C overnight. After washing with PBS, the wells 
were blocked with 5% skim milk for 1 h, and 50 μl of FITC-labeled fibronectin (0 
to 20 μg/ml) was added at 37°C for 1 h in the presence or absence of non-labeled 
fibronectin (0 to 10 μg/ml). After washing with PBS, 100 μl of PBS was added to 
each well, and the fluorescence was measured with a fluorometer (FLUO Star). To 
evaluate Td92 binding to immobilized fibronectin, 96-well microtiter plates were 
coated with 100 μl of fibronectin (10 μg/ml) or 100 μl of skim milk (5 μg/ml) at 
4°C overnight. After washing with PBS, the wells were blocked with 5% skim milk 
for 1 h, and FITC-labeled Td92 (0 to 10 μg/ml) was added at 37°C for 1 h. To 
examine the binding of Td92 to fibronectin was dependent on the RGD sequence, 
the RGD peptide (GRGDSP, 31 to 250 μg/ml) was added to the wells prior to the 
addition of 50 μl of FITC-labeled Td92 (5 μg/ml). After washing with PBS, 100 μl 
of PBS was added to each well and the fluorescence was measured with a 
fluorometer.  
 
2.27. Integrin α5β1 detection by immunofluorescent staining 
THP-1 cells (1 x 105 cells/500 μl) were differentiated into macrophages with 
0.5 μM of PMA on a cover glass (Ф12 mm) placed in a 24-well plate. The cells 
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were washed with PBS and pretreated with 2.5 μM cytochalasin D for 30 min 
before incubation with FITC-labeled Td92 (10 μg/ml) for 2 h. The cells were fixed 
with 3.8% paraformaldehyde in PBS and were blocked with 2% human serum in 
PBS. The cells were then incubated with the integrin α5β1 Ab (2 μg/ml) followed 
by incubation with a Cy3-conjugated secondary Ab (1 μg/ml) in 2% human serum 
in PBS. To stain the nucleus, the cells were stained with 10 μM Hoechst 33342. 
The cells were analyzed for colocalization of Td92 with integrin α5β1 on the cell 
membrane by confocal laser scanning microscopy (x 2000, Olympus FV300, 
Tokyo, Japan).  
To assess the formation of integrin clustering upon Td92 binding, the THP-1 
cells (1 x 105 cells/500 μl) were differentiated into macrophages with 0.5 μM of 
PMA on a cover glass (Ф12 mm) placed in a 24-well plate. The cells were treated 
with Td92 (10 μg/ml), fibronectin (20 μg/ml), or heat-inactivated BSA (10 mg/ml) 
for 15, 60, and 120 min. After washing, the cells were fixed with 3.8% 
paraformaldehyde in PBS and immunostained using an integrin α5β1 Ab and a 
Cy3-conjugated secondary Ab. Cells were analyzed by confocal laser scanning 
microscopy. A representative cell for each treatment is shown. Magnification, x 
2000 
 
2.28. NF-κB activation assay  
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THP-1 cells (1 x 105 cells/500 μl) were seeded on a cover glass (Ф12 mm) 
placed in a 24-well plate and were differentiated with 0.5 μM PMA for 3 h. The 
cells that were or not transfected using siRNA specific for MyD88 or TRIF were 
incubated in serum-free media for 24 h. After washing with PBS, the cells were 
stimulated with 10 μg/ml of Td92, 10 μg/ml of PP4, MOI 1000 of T. denticola, 10 
ng/ml of TNF-α, or 10 μg/ml of LPS for 1 h. In some experiments, the cells were 
pretreated with the integrin α5β1 Ab (10 μg/ml) or the anti-mouse IgG1 isotype 
control (10 μg/ml) for 1 h or 300 μM oxATP for 30 min before stimulation for 1 h. 
After washing with PBS, the cells were fixed with 3.8% paraformaldehyde in PBS, 
permeabilized with chilled methanol, and blocked with 2% human serum in PBS. 
The cells were incubated with an anti-human NF-κB p65 Ab (1 μg/ml) and a Cy3-
conjugated secondary Ab (1 μg/ml) in 2% human serum in PBS. The nucleus of the 
cells was stained with 10 μM Hoechst 33342, and the subcellular localization of 
NF-κB was observed by a confocal laser scanning microscopy (x 2000 and x 400, 
Olympus FV300, Tokyo, Japan). Images of six microscopic fields per treatment 
(well) were taken at x 400 magnification, and the percentage of cells with mainly 
nuclear NF-κB p65 was calculated using NIH Image J. A total of at least 500 cells 
were counted for each experimental condition.   
To determine the relationship between Td92-induced NF-κB activation and 
caspase-1 activation, PMA-differentiated THP-1 cells (2 x 106 cells/ml in 6-well 
plates) were pretreated with Bay-117082 (5 and 10 μM) for 30 min before 
stimulation with Td92 (10 μg/ml) or LPS (10 μg/ml) for 6 h. LPS-stimulated cells 
were pulsed with 2.5 mM ATP for 30 min. Procaspase-1 and proIL-1β in the cell 
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extracts and their active forms secreted in the supernatant and precipitated by 10% 
TCA were analyzed by immunoblotting. 
 
2.29. Enyme-linked immunosorbent assay (ELISA) 
The culture supernatants of the cells treated with Tp92 homologs were 
assayed to determine IL-1β, TNF-α, IL-6, IL-8 and PGE2 levels in the presence or 
absence of blocking antibodies using the ELISA kits from R&D Systems™ 
(Minneapolis, MN, USA). 
 
2.30. Statistical analysis  
Statistically significant differences between samples were analyzed with an 
unpaired, one-tailed Student’s t test. The data are shown as the mean ± SD. A p 
value of ＜0.05 was considered statistically significant 
 
2.31. Nucleotide sequence accession number  
DNA sequences of the tp92 gene homologs have been submitted to the 
GenBank database under accession no. EU057146 for tl88 of T. lecithinolyticum, 





3.1. Identification and characterization of Tp92 homologs of oral 
treponemes 
3.1.1. Distribution of tp92 gene homologs in oral treponemes  
tp92 gene homologs were identified from the genome sequence of T. denticola 
(ATCC 35405, TDE2601 ORF), which has been denoted as a putative surface 
antigen, and by sequencing of the PCR products of the genes that were amplified 
with degenerate and specific primers for T. lecithinolyticum, T. maltophilum, and T. 
socranskii subsp. socranskii. The ORFs of the tp92 homologs from T. denticola, T. 
lecithinolyticum, T. maltophilum and T. socranskii subsp. socranskii were 2457 bp 
(818 amino acid residues), 2430 (809 aa), 2430 (809 aa), and 2442 bp (813 aa), 
respectively.  
The translated amino acid sequences of the tp92 homologs in the oral 
treponemes revealed a significant homology with that of T. pallidum Tp92. The 
Tp92 homologs from the four oral treponemes showed an amino acid sequence 
identity of 37.9-49.3% and a similarity of 54.5-66.9% with Tp92 (Table 1). The 
sequence identity and similarity between the Tp92 homologs from the oral 
treponemes were 41.6-71.6% and 59.9-85.6%, respectively. The Tp92 homologs 
showed sequence identities of 28.4-30.2% and 22.2-23.7% and similarities of 46.9-
49.7% and 37.0-39.4% with two nonoral spirochetes, Borrelia burgdorferi B31 and 
Leptospira interrogans serovar Copenhageni, respectively.  
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All Tp92 homologs have N-terminal signal peptide sequences. The program 
SignalP identified a 20-aa signal sequence for T. denticola, 27-aa for T. 
lecithinolyticum, 25-aa for T. maltophilum, and 31-aa for T. socranskii subsp. 
socranskii. A cleavable 21-aa N-terminal signal sequence has been identified in 
Tp92 of T. pallidum [18]. PSORTb predicted the localization of the Tp92 
homologs from the four oral treponemes to the outer cell membrane with 
likelihoods of more than 94% (94.5% for T. denticola, 100% for T. lecithinolyticum, 
T. maltophilum, and T. socranskii). The predicted pI and molecular mass of the 
mature Tp92 homologs were 5.79/91.55-kDa for T. denticola, 6.34/88.33-kDa for T. 
lecithinolyticum, 5.54/88.58-kDa for T. maltophilum, and 5.46/88.03-kDa for T. 
socranskii subsp. socranskii, as predicted by the ProtParam tool from ExPASy. The 
pI and molecular mass of Tp92 are 8.27/91.97-kDa. The Tp92 homologs were 
named Td92 for T. denticola, Tl88 for T. lecithinolyticum, Tm88 for T. 












Table 1. Degrees of amino acid sequence homology of the Tp92 homologs 
Bacterium 
% Identity/% similarity of Tp92 homologs from the indicated species 












serovar    
Copenhageni 
  T. denticola 100       
T. lecithin- 
olyticum 
44.0/63.3 100      
  T. maltophilum 43.5/61.2 71.6/85.6 100     
  T. socranskii 41.6/59.9 47.3/66.8 46.9/67.2 100    
  T. pallidum 49.3/66.9 39.6/57.5 38.2/57.4 37.9/54.5 100   
B.burgd- 
orferi B31  















 3.1.2. Purification of recombinant Tp92 homologs  
The tp92 gene homologs were successfully expressed in E. coli using the 
pQE-30 vector after PCR and TA cloning (Fig. 1). As expected from the deduced 
amino acid sequence, the molecular size of the recombinant Tp92 homologs was 
approximately 92-kDa for T. denticola and 88-kDa for T. lecithinolyticum, T. 
maltophilum, and T. socranskii subsp. socranskii. The recombinant proteins formed 
in the inclusion bodies were purified by solubilization, renaturation, and affinity 
chromatography using Ni-NTA agarose. These proteins were used to study host 
cell stimulation after further purification to remove any possible E. coli LPS 














Figure 1. The tp92 gene homologs are expressed in E. coli. The tp92 gene 
homologs were cloned in E. coli and the expression of histidine-tagged 
recombinant proteins was analyzed by SDS-PAGE (10% polyacrylamide gel, A) 
and by immunoblotting with a histidine Ab (B) after induction with IPTG. Lanes: 
Td92, Tp92 homolog of T. denticola; Tl88, Tp92 homolog of T. lecithinolyticum; 
Tm88, Tp92 homolog of T. maltophilum; Tss88, Tp92 homolog of T. socranskii 
subsp. socranskii. (–), noninduced E. coli cell lysates; (+), IPTG-induced E. coli 








3.1.3. Cross-reactivity of Tp92 homologs with antiserum raised against Td92  
An IgG fraction of antisera raised against recombinant Td92 (Td92 Ab) was 
purified and tested for reactivity with T. denticola and the recombinant Tp92 
homologs. Immunoblot analysis showed that the antibodies reacted with a 92-kDa 
protein band in T. denticola lysates and with the recombinant Td92 (Fig. 2A). 
Immunodot blot analysis showed that the Td92 Ab cross-reacted with Tl88, Tm88, 
and Tss88 (Fig. 2B), whereas it did not react with an irrelevant histidine-tagged 















Figure 2. Td92 Ab cross-reacts with T. denticola whole cell lysates (WC) and 
Tp92 homologs. T. denticola whole cell lysates (WC, 10 mg) and Td92 were 
subjected to SDS-PAGE (8% polyacrylamide gel) followed by immunoblotting 
with a Td92 Ab (A). The applied amounts of Td92 were 500 ng in SDS-PAGE and 
100 ng in immunoblot. The cross-reactivity of the Tp92 homologs with the Td92 
Ab was examined by an immunodot blot assay. The Tp92 homologs (250 ng in 1 
ml) were applied onto a nitrocellulose membrane and reacted with the Td92 Ab. As 
a negative control, E. coli lysates and an irrelevant recombinant protein, MspTL, 
were included (B). The detection was performed using HRP-labeled mouse anti-




3.1.4. Outer membrane location of Td92 in T. denticola  
The computer-assisted analysis using the PSORTb program predicted that the 
Tp92 homologs were outer membrane proteins as described above. The surface 
location of T. denticola Td92 was empirically evaluated using various techniques. 
First, the presence of Td92 in the OM isolated from T. denticola was examined 
using a Td92 Ab. As shown in Fig. 3, the Td92 Ab raised against recombinant 
Td92 recognized a single protein band at 92-kDa in the OM preparation. The FlaA 
Ab detecting the periplasmic protein FlaA of T. denticola did not react with the 
OM fraction, but it reacted with a 37-kDa protein in the whole cell lysates, 
verifying the purity of the OM. Second, the ability of the intact bacteria to react 
with the Td92 Ab was assessed using indirect immunofluorescence. Because of the 













Figure 3. The Td92 is located in the outer membrane of T. denticola. T. 
denticola outer membrane was prepared and subjected to SDS-PAGE (10% 
polyacrylamide gel) followed by immunoblotting with a Td92 Ab and a FlaA Ab. 
The detection was performed using HRP-labeled mouse anti-rabbit IgG and TMB 
as HRP substrates. WC, T. denticola whole cell lysates (10 mg); OM, outer 








As shown in Fig. 4, non-fixed T. denticola was stained with the Td92 Ab but 
did not stain with the FlaA Ab. Acetone-fixed and permeabilized T. denticola 
reacted with both antibodies, indicating that the OM of the bacteria was intact and 
that Td92 was surface-exposed. Furthermore, as shown in Fig. 5, the Td92 Ab 
reacted with T. denticola cells, indicating that the Td92 epitopes were surface-
exposed. The antibody also cross-reacted with T. lecithinolyticum, T. maltophilum, 
and T. socranskii subsp. socranskii, suggesting the presence of common surface 
epitopes of the homologous proteins in these bacteria. The IgG isotype did not 
react with the bacteria. The cross-reactivity of the Td92 Ab by 
immunofluorescence (Fig. 5) was coincident with that observed in immunodot blot 
assay (Fig. 2B). Immunogold electron microscopy further showed that gold 
particles bound to the bacterial surface (Fig. 6). Third, flow cytometric analysis 
using a Td92 Ab showed that more than 80% of non-fixed T. denticola cells were 
immunopositive, while a minor portion of the bacteria was detected with the FlaA 
Ab (Fig. 7A). Most of the acetone-fixed and permeabilized bacteria were 
immunopositive with both antibodies (Fig. 7B). Isotype-matched Ab (rabbit IgG) 








Figure 4. The Td92 is surface-exposed in T. denticola. Non-fixed (A) and 
acetone-fixed/permeabilized T. denticola cells (B) were reacted with a Td92 Ab or 
a FlaA Ab followed by reacting with FITC-labeled anti-rabbit IgG. The same cells 
were further stained with Hoechst dye, a fluorescent nucleic acid stain. The images 
of the same fields were obtained from immunoflorescence and Hoechst dye 










Figure 5. The Td92 Ab cross-reacts with the Tp92 homologs of oral 
treponemes. Freshly grown Treponema species were fixed with 4% 
paraformaldehyde and reacted with a Td92 Ab or a isotype matched Ab (rabbit 
IgG; lower right), followed by reacting with FITC-labeled goat anti-rabbit IgG. 










Figure 6. The Td92 Ab binds to the surface of T. denticola. T. denticola was 
reacted with a Td92 Ab and subsequently with the anti-rabbit IgG conjugated with 
10-nm colloidal gold particles. After negative staining with 1% uranyl acetate, the 
bacteria were observed by a transmission electron microscopy. T. denticola whole 
cell (A), a part of the bacterium showing immunogold labeling with the Td92 Ab 
(B), or immunogold labeling with the isotype matched Ab (rabbit IgG) (C). Scale 







Figure 7. Td92 is expressed in surface of T. denticola. Non-fixed (A) and 
acetone-fixed/permeabilized T. denticola cells (B) were reacted with a Td92 Ab or 
a FlaA Ab followed by reacting with FITC-labeled goat anti-rabbit IgG. The cells 
were then analyzed by flow cytometry. Isotype-matched Ab (rabbit IgG) was used 
as a negative control. The experiments were performed three times, and 








3.1.5. Binding of the Tp92 homologs to KB cells  
Bacterial binding to the host cells is an initial step in the colonization of 
pathogens. To determine whether the Tp92 homologs function as adhesins, the 
binding capacity of the Tp92 proteins to KB cells, an epithelial cell line, was 
examined. As shown in Fig. 8, the FITC-labeled Tp92 homologs were able to bind 
to the cells. To test whether this binding was specific, a competitive binding 
inhibition assay was performed using fluorescently labeled T. denticola cells and 
unlabeled Td92. As shown in Fig. 9, binding of CFSE-labeled T. denticola to KB 
cells was inhibited by unlabeled Td92 in a dose-dependent manner, whereas an 
irrelevant recombinant protein (PP4) with a histidine tag did not inhibit the binding 













Figure 8. The Tp92 homologs bind to KB cells. KB cells (1 x 105/500 μl) were 
cultured in 24-well plates to confluence, and incubated with FITC-labeled Tp92 
homologs (2.5 μg of protein) at 37°C for 1 h. The cells were detached and washed 
with PBS, and the fluorescence of bound proteins was measured using a 
fluorometer. Protein adhesion was expressed as a percentage of total proteins added. 
The experiments were repeated three times and similar results were obtained. The 











Figure 9. The Td92 inhibits T. denticola binding to KB cells. KB cells (1 x 105 
cells/500 μl) were cultured in 24-well plates and incubated with CFSE-labeled T. 
denticola whole cells (100 μl of a culture with an OD600 of 0.2 or 5 x 108 bacteria) 
in the presence of Td92 at different concentrations for 1 h. After the cells were 
detached and washed with PBS, the fluorescence of bound bacteria was measured 
by a fluorometer. An irrelevant recombinant protein (PP4) was used as a negative 
control. The experiments were repeated three times, and similar results were 
obtained. The results are presented as means ± SD in triplicate samples and are 







3.1.6. Host cell responses to the Tp92 homologs  
Prior to stimulation of the host cells with the recombinant Tp92 homologs, 
endotoxin decontamination of the recombinant proteins was verified using 
CHO/CD14/TLR4 cells that expressed CD25 upon TLR4-dependent NF-κB 
activation. The Tp92 homologs did not cause an increase in CD25 expression in the 
cells, whereas LPS significantly increased the expression of CD25 (Fig. 10). 
 
Figure 10. Endotoxin decontamination of Td92 homologs is verified using NF-
κB reporter cell line. CHO/CD14/TLR4 cells (1x105 cells/well) were treated with 
Tp92 homologs (10 μg/ml), and E. coli LPS (1 μg/ml) for 16 h. The cells were 
stained with FITC-labeled anti-human CD25 Ab for 30 min at 4°C. The expression 
was analyzed by flow cytometry. The results are presented as means ± SD in 
triplicate samples. LPS-treated cells were used as a positive control. The results are 




Using THP-1 and PDL cells, the regulation of representative proinflammatory 
and osteoclastogenic factors that are known to stimulate RANKL, which is 
involved in osteoclastogenesis leading to bone resorption, were analyzed. 
Monocytes are among the early immune cells that react to the local presence of 
bacteria, and PDL is a supporting tissue linking the root surface and alveolar bone. 
As shown in Fig. 11, the addition of the Tp92 homologs significantly upregulated 
IL-1β, TNF-α, IL-6 and IL-8 in THP-1 cells when introduced at a concentration of 
10 μg/ml, both at the mRNA and protein levels, as analyzed by real-time qPCR and 
ELISA, respectively. In PDL cells, IL-6 and IL-8 were upregulated by the Tp92 
homologs (Fig. 11). The expression of COX-2 and its product, PGE2, was also 
induced by the Tp92 homologs in both THP-1 and PDL cells (Fig. 12). In a gelatin 
zymography assay, the Tp92 homologs induced a gelatinolytic activity with a 











Figure 11. The proinflammatory factors are up-regulated by the Tp92 
homologs in THP-1 and PDL cells. THP-1 cells (1 x 106/ml) or PDL cells (5 x 
105/ml) were cultured and treated with the Tp92 homologs (10 μg/ml) or LPS (10 
μg/ml) for 8-24 h. RNA was isolated from the cells and subjected to real-time 
qPCR (A) and the conditioned media were used for ELISA (B). LPS-treated cells 
were used as a positive control. The results are presented as means ± SD in 





Figure 12. COX-2 and PGE2 are up-regulated by the Tp92 homologs in THP-1 
and PDL cells. THP-1 (A, 1 x 106/ml) and PDL cells (B, 5 x 105/ml) were cultured 
and treated with the Tp92 homologs (10 μg/ml) or LPS (10 μg/ml) for 12-24 h. 
RNA was isolated from the cells and COX-2 mRNA expression was analyzed by 
real-time qPCR. The conditioned media were used for measuring PGE2 levels by 
ELISA. LPS-treated cells were used as a positive control. The results are presented 








Figure 13. MMP-9 is up-regulated by the Tp92 homologs in THP-1 cells. THP-
1 cells (1 x 106/ml) were treated with the Tp92 homologs (10 μg/ml) or LPS (10 
μg/ml) for 12-24 h. RNA was isolated from the cells and MMP-9 mRNA 
expression was analyzed by real-time qRT-PCR (A). The conditioned media were 
used for analyzing MMP-9 expression by gelatin zymography (B). LPS-treated 
cells were used as positive control. The results are presented as means ± SD in 







3.2. A novel function of integrin α5β1 in the activation of innate 
immune components by Td92 
3.2.1. Activation of caspase-1 and IL-1β by T. denticola and Td92   
As shown Fig. 11, Td92, a Tp92 homolog of T. denticola, induced IL-1β 
mRNA expression and secretion in the monocyte cell line THP-1. Because IL-1β is 
secreted in the mature form and IL-1β maturation occurs by cleavage of the N-
terminal 116-amino acids of the inactive cytosolic proIL-1β (p31) by caspase-1, it 
was firstly determined whether Td92 and T. denticola could activate caspase-1 and 
induce proIL-1β maturation in THP-1 cells. Caspase-1 is also expressed as a 
proenzyme (45-kDa) composed of three domains, the N-terminal pro-domain, the 
p20 subunit (20-kDa), and the p10 subunit (10-kDa), of which the latter two 
domains are the essential caspase catalytic domains and form a catalytic tetramer 
[52]. Because caspase-1 is constitutively activated in undifferentiated THP-1 cells 
and monocytes but not in macrophages [53, 54],  
PMA-differentiated THP-1 cells were used throughout this study to assess the 
effect of Td92 on caspase-1 activation and IL-1β secretion. As shown in Fig. 14A, 
Td92 activated caspase-1 in a dose-dependent manner in THP-1 cells, and the level 
of the processed p20 subunit in the culture supernatants increased with increased 
Td92, as detected by immunoblotting. An irrelevant recombinant protein (PP4), 
which is a C-terminal partial peptide of the surface protein MspTL of Treponema 
lecithinolyticum, an oral spirochete that does not have a cell-stimulating activity 
[45], was used as a negative control. All of the chemicals used for the preparation 
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of PP4 were from the same batches that were used for the Td92 preparation. MDP 
plus ATP was used as a positive control. Truncated recombinant Td92 polypeptides 
were also included to examine their ability to activate caspase-1. Td92 was divided 
into two fragments according to the structural analysis of the protein using 
MODELLER [55]: the G-domain (Td-G, 46-kDa) corresponded to the amino acid 
positions 1-400 and the B-domain (Td-B, 45.5-kDa) corresponded to the amino 
acid positions 401-798. According to the structure prediction, the G-domain is a 
globular domain expected to perform a specific biological function, and the B-
domain is a membrane-spanning beta-barrel domain. The G-domain activated 
caspase-1 and induced proIL-1β expression, but the B-domain did not. The Tp92 
homologs of oral treponemes also activated caspase-1 and induced proIL-1β 
expression (Fig. 14B). These results strengthen the hypothesis that Td92 has 
specific effects on caspase-1 activation and proIL-1β expression. Dose-dependent 
caspase-1 activation was also observed when THP-1 cells were treated with live T. 
denticola at a multiplicity of infection (MOI) of 100, 500, or 1000. The dose- and 
time-dependent release of active IL-1β following the addition of Td92 or live 
bacteria was detected in culture supernatants by ELISA (Fig. 14C and 14D). A 
significant release of IL-1β was observed after a 3 h treatment with Td92 (10 




Figure 14. Tp92 homologs and live T. denticola induce caspase-1 activation 
and IL-1β secretion. THP-1 cells were treated with Tp92 homologs (Td92, Tl88, 
Tm88, and Tss88), live T. denticola, PP4, truncated Td92 (Td-G and Td-B domain), 
or MDP for 1 to 12 h (6 h in A-C). MDP-stimulated cells were then pulsed with 2.5 
mM ATP for 30 min. Caspase-1 and IL-1β secreted into the culture supernatants 
(sup) and procaspase-1, proIL-1β, and β-Actin in the cell lysates (cell) were 
detected by immunoblotting. The β-Actin was used as a loading control (A-B). The 
IL-1β level in the culture supernatants was analyzed by ELISA. The data are shown 
as the means ± SD of one representative experiment of three performed in triplicate. 
*p < 0.01 versus unstimulated cells (C-D) 
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To confirm that the Td92-induced IL-1β activation was caused by caspase-1 
activation, the cells were pretreated with the caspase-1-specific inhibitors z-
YVAD-fmk and ac-YVAD-cho prior to Td92 treatment. As shown in Fig. 15, z-
YVAD-fmk and ac-YVAD-cho inhibited the caspase-1 activation and IL-1β 
secretion induced by Td92, indicating that IL-1β activation by Td92 is caspase-1-
dependent.  
 
Figure 15. Td92-induced IL-1β activation was caused by caspase-1 activation. 
THP-1 cells were pretreated with z-YVAD-fmk or ac-YVAD-cho for 30 min 
before stimulation with Td92 for 6 h. Caspase-1 and IL-1β in the culture 
supernatants (sup) and β-Actin in the cell lysates (cell) were detected by 
immunoblotting. The band intensities on the immunoblots were quantified using 
NIH Image J software and are presented as the relative ratio to β-Actin.   
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In addition to caspase-1 activation, Td92 and T. denticola induced proIL-1β 
expression in the cells (Fig. 14A). Because recombinant Td92 was used, control 
experiments were performed to verify that the Td92 activity was not attributable to 
endotoxin contamination. First, IL-1β secretion in response to native and 
recombinant Td92 after heating (95°C for 1 h) was compared. Similar to the 
recombinant Td92, heat-treated native Td92 significantly reduced IL-1β secretion, 
but not completely, compared with the untreated native Td92 (Fig. 16). Native and 
recombinant Td92 from three independent purifications were used and provided 
similar results. In repeated experiments, heated Td92 (10 μg/ml) reduced IL-1β 
secretion by 56-65%. In contrast to that of LPS, the activity of Td92 was 
remarkably reduced by heating but not by polymyxin B, an endotoxin inhibitor 
(Fig. 17). The activity of Td92 to induce IL-1β secretion was not altered after 
extraction with 1% Triton X-114, which is an efficient method to dissociate 
endotoxins from biomolecules, whereas LPS completely lost its activity after 
Triton X-114 extraction (Fig. 18). The endotoxin activity of the recombinant Td92 
was 0.37 EU/μg of the protein and approximately 1/30,000 that of Escherichia coli 









Figure 16. Heat treatment significantly reduces Td92-induced IL-1β secretion. 
PMA-differentiated THP-1 cells (1 x 106 cells/500 μl in 12-well plates) were 
treated with native or recombinant Td92 before or after heating (95°C for 1 h) for 6 
h. The IL-1β level in the culture supernatants was analyzed by ELISA. The 
experiments were performed three times and representative data are shown. *p < 










Figure 17. Polymyxin B treatment does not affect Td92-induced IL-1β 
secretion. PMA-differentiated THP-1 cells (1 x 106 cells/500 μl in 12-well plates) 
were pretreated with polymyxin B (5 and 10 μg/ml) for 1 h before stimulation with 
LPS (1 μg/ml), heated LPS (1 μg/ml), Td92 (10 μg/ml), or heated-Td92 (10 μg/ml) 
for 6 h. The IL-1β level in the culture supernatants was analyzed by ELISA. LPS-
treated cells were incubated with 1% FBS and pulsed with 2.5 mM ATP for 30 min. 
LPS and Td92 were heated at 95°C for 1 h. The experiments were performed three 
times, and representative data are shown. *p < 0.01 versus LPS-stimulated cells; #p 







Figure 18. Triton X-114-extracted Td92 maintains its ability to induce IL-1β 
secretion. Td92 (250 μg) or LPS (100 μg) was mixed with 1% Triton X-114 in a 
total volume of 1 ml and incubated at 4°C for 30 min with constant stirring. After 
further incubation at 37°C for 10 min, the samples were centrifuged at 16,000 x g 
for 30 min at 25°C and the upper aqueous phase was carefully removed. The Triton 
X-114 extraction was repeated for two more cycles, and the resulting aqueous 
phase were used for cell treatments. As a control, PBS extracted with Triton X-114 
was included. PMA-differentiated THP-1 cells (1 x 106 cells/500 μl in 12-well 
plates) were treated with Td92 (10 μg/ml) or LPS (1 μg/ml) for 6 h. The IL-1β 
level in the culture supernatants was analyzed by ELISA. The experiments were 





Furthermore, transfection with TLR4 siRNA did not affect Td92-induced 
proIL-1β expression, whereas it inhibited E. coli LPS-induced proIL-1β expression 
compared to nontransfected cells (Fig. 19). I also tested whether native Td92 
extracted from T. denticola induces proIL-1β expression and activates caspase-1. 
Native Td92 exerted the same activities as the recombinant protein (Fig. 20). These 
results indicate that Td92 induces both proIL-1β expression and caspase-1 
















Figure 19. Knockdown of TLR4 does not affect Td92-induced proIL-1β 
expression. THP-1 cells transfected with TLR4 siRNA were treated with Td92 or 
LPS for 6 h. LPS-stimulated cells were then pulsed with 2.5 mM ATP for 30 min. 
IL-1β secreted into the culture supernatants (sup), proIL-1β and β-Actin in cell 
lysates (cell), and TLR4 knockdown by siRNA (lower panel) were detected by 
immunoblotting. The band intensities on the immunoblots were quantified using 






Figure 20. Native Td92 induces caspase-1 activation and IL-1β secretion. THP-
1 cells were stimulated with various concentrations of native Td92 for 6 h. 
Caspase-1 and IL-1β in the culture supernatants (sup) and procaspase-1, proIL-1β, 
and β-Actin in the cell lysates (cell) were detected by immunoblotting. The band 
intensities on the immunoblots were quantified using NIH Image J software and are 








3.2.2. Td92-induced caspase-1 activation via the NLRP3 inflammasome 
Caspase-1 activation is initiated by the different inflammasome components. 
NLRs, such as NLRP3 and NLRC4, are the representative inflammasome 
components that have been shown to be involved in caspase-1 activation. To 
determine the component of inflammasome involved in Td92-induced caspase-1 
activation, the roles of NLRP3, ASC, and NLRC4 were examined using siRNA 
technology. Because ASC is known to be an essential component of the NLRP3 
inflammasome, the ASC knockdown experiment was also performed. Transfection 
of THP-1 cells with each siRNA resulted in a marked reduction in the expression 
of the corresponding mRNA and protein as assessed by real-time qPCR and 
immunoblotting, respectively, compared to cells transfected with control siRNA 
(Fig. 21). When Td92 was added to THP-1 cells transfected with NLRP3-specific 
siRNA (Fig. 21A) or ASC-specific siRNA (Fig. 21B), the p20 subunit of caspase-1 
was markedly decreased, while the knockdown of NLRC4 did not affect the active 
caspase-1 level induced by Td92 (Fig. 21C). Accordingly, the decrease in the 
active form of caspase-1 resulted in a decrease in IL-1β secretion. MDP/ATP, 
Salmonella typhimurium flagellin, and E. coli RNA were used as positive controls 
for NLRP3 inflammasome-, NLRC4 inflammasome-, and ASC-dependent caspase-
1 activation, respectively. The present results indicate that Td92 activates the 






Figure 21. Td92-induced IL-1β activation is mediated via NLRP3. THP-1 cells 
were transfected with NLRP3 siRNA (A), ASC siRNA (B), NLRC4 siRNA (C), or 
control siRNA for 18 to 48 h. To confirm RNA interference, half of the cells were 
used for RNA extraction followed by real-time qPCR, and the other half of the 
cells were subjected to immunoblotting with antibodies for NLRP3 (A), ASC (B), 
and NLRC4 (C). Also, siRNA-transfected cells were treated with Td92, MDP, E. 
coli RNA, or S. typhimurium flagellin for 6 h (flagellin was delivered into the 
cytosol using the Profect P1 protein transfection reagent). MDP-stimulated cells 
were pulsed with 2.5 mM ATP for 30 min. Caspase-1 and IL-1β in the culture 
supernatants (sup) and β-Actin in cell lysates (cell) were detected by 
immunoblotting. The real-time qPCR data are shown as the means ± SD of one 
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representative experiment of three performed in triplicate. The band intensities on 
the immunoblots were quantified using NIH Image J software and are presented as 

















3.2.3. ROS generation by Td92 
Reactive oxygen species (ROS) are among the most important factors of 
inflammasome activation. Recently, it has been reported that inflammasome 
activation is triggered by reactive oxygen species, which are generated by a 
NADPH oxidase upon particle phagocytosis. ROS are generated by a NADPH 
oxidase, which is implicated in NALP3 inflammasome activation [56]. To 
determine whether ROS are generated by Td92, THP-1 cells were incubated with 
the ROS-sensitive fluorescent dye 2’.7’-dichlorodihydrofluorescein diacetate 
(DCF-DA) before treatment with Td92. As shown in Fig. 22A, the production of 
ROS was triggered by stimulation with Td92, compared with no treatment. To 
further examine whether Td92 induced ROS generation through NADPH oxidase 
in inflammasome activation, THP-1 cells were pretreated with ROS inhibitors 
(NAC and PDTC) and NADPH oxidase inhibitors (apocynin and DPI) before 
stimulation with Td92. As shown in Fig. 22B, the Td92-induced caspase-1 and IL-
1β secretion were partially reduced by ROS inhibitors (NAC and PDTC) and by 
NADPH oxidase inhibitors (Apocynin and DPI). Although Td92-induced caspase-
1 activation could not be completely inhibited by these inhibitors, the Td92-






Figure 22. Td92 induces ROS generation through NADPH oxidase. THP-1 
cells (2x105cells/ml) were seeded at 96-well culture plates and differentiated into 
macrophages with 160 nM PMA for 72 h. The cells were incubated with 10 µM 
DCF-DA at 37°C for 30 min and then the cells were washed with serum-free media 
followed by exposure to Td92 (10 μg/ml), LPS (10 μg/ml), or H2O2 (100 µM) for 1 
h. ROS generation of cells was detected using a fluorometer (excitation at 485nm 
and emission at 520nm). The experiments were repeated three times and similar 
results were obtained. The results are presented as means ± SD in triplicate samples. 
*p < 0.05 versus unstimulated cells (A) THP-1 cells (2 x 106/ml) were pretreated 
with 20 mM NAC, 50 µM PDTC, 100 µM apocynin, or 20 µM DPI for 30 min and 
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cells were then stimulated with Td92 (10 µg/ml), or MDP (10 µg/ml) for additional 
6 h. MDP-stimulated cells were then pulsed with 2.5 mM ATP for 30 min. 
Caspase-1 and IL-1β secreted into the culture supernatants (Sup) and procaspase-1, 
proIL-1β, and β-Actin in the cell lysates (Cell) were detected by immunoblotting. 
















3.2.4. Association of ATP with Td92-induced caspase-1    
The NLRP3 inflammasome can be specifically activated by a danger signal, 
such as ATP, which is released from stressed cells [35, 57, 58]. Extracellular ATP 
is an inflammatory mediator that binds to the P2X7 receptor and is involved in 
caspase-1 activation in macrophages and epithelial cells. To examine whether Td92 
induces ATP release, which in turn leads to caspase-1 activation, THP-1 cells were 
treated with Td92 or T. denticola, and the ATP levels in the culture supernatants 
were measured. Td92 (10 µg/ml) and live T. denticola at an MOI of 100 and 1000 
significantly induced ATP release, whereas PP4 did not enhance ATP production 
(Fig. 23A). To determine whether there is a link between the ATP produced by 
Td92 and caspase-1 activation, THP-1 cells were treated with oxATP, the 
irreversible P2X7 antagonist that blocks the interaction of ATP with the P2X7 
receptor. As shown in Fig. 23B, oxATP at 300 μM completely blocked caspase-1 
and IL-1β activation induced by Td92, indicating that Td92-induced caspase-1 
activation is mediated by ATP. Furthermore, oxATP treatment inhibited the 
induction of proIL-1β by Td92. These results suggest that ATP has a critical role in 





Figure 23. ATP is involved in Td92-induced NLRP3 activation. THP-1 cells 
were stimulated with Td92, live T. denticola, or PP4 for 2 h. Extracellular ATP 
levels were determined by using an ATP bioluminescence assay Kit. The data are 
shown as the means ± SD of one representative experiment of three performed in 
triplicate. *p < 0.01 versus unstimulated cells (A) For the inhibition assay, the cells 
were pretreated with oxATP for 30 min prior to stimulation with Td92 for 6 h. 
Caspase-1 and IL-1β secreted into the culture supernatants (sup) and procaspase-1, 
proIL-1β, and β-Actin in the cell lysates (cell) were detected by immunoblotting. 
The band intensities of the immunoblots were quantified using NIH Image J 





3. 2.5. K+ efflux as a mechanism of Td92-induced inflammasome activation 
Depletion of intracellular K+ is one of the mechanisms that leads to NLRP3 
inflammasome activation, and in vitro, millimolar amounts of ATP induce a rapid 
collapse of ionic gradients by activating the purinergic receptor P2X7R, an ATP-
gated cation channel, and cause K+ efflux [35, 59]. To examine the role of K+ 
efflux in the Td92-induced inflammasome activation, THP-1 cells were treated 
with Td92 in the presence of high concentrations of KCl in the culture medium that 
would block K+ efflux from the cells. KCl treatment significantly reduced Td92-
mediated caspase-1 activation and proIL-1β expression (Fig. 24A). 
  To further examine the role of K+, caspase-1 activation was analyzed after 
THP-1 cells were treated with Td92 in the presence of the ATP-sensitive potassium 
channel blockers glybenclamide (also known as glyburide) and tolbutamide. As 
shown in Fig. 24B and 24C, both inhibitors decreased the extent of caspase-1 
activation induced by Td92. These results indicate that Td92 increases plasma 
membrane permeability via ATP, resulting in K+ efflux. K+ efflux is sensed by 
NLRP3 and is followed by caspase-1 recruitment, inflammasome formation, and 
caspase-1 activation. Interestingly, proIL-1β expression in the cell extracts was 
decreased by glybenclamide but not by tolbutamide. Glybenclamide inhibited the 
caspase-1 activation, and IL-1β secretion induced by LPS plus ATP, targeting a 





Figure 24. K+ efflux is involved in Td92-induced NLRP3 activation. THP-1 
cells were stimulated with Td92 for 6 h after pretreatment with KCl (A), 
glybenclamide (B), or tolbutamide (C) for 30 min prior to stimulation with Td92 
for 6 h. Caspase-1 and IL-1β secreted into the culture supernatants (sup) and 
procaspase-1, proIL-1β, and β-Actin in the cell lysates (cell) were detected by 
immunoblotting. The band intensities of the immunoblots were quantified using 





3. 2.6. Caspase-1-dependent proinflammatory cell death induced by Td92   
In addition to processing the proinflammatory cytokines proIL-1β and proIL-
18 into their mature forms, caspase-1 can initiate a proinflammatory cell death 
called pyroptosis. Because T. denticola and Td92 activate caspase-1 via the NLRP3 
inflammasome, the release of lactate dehydrogenase (LDH), a marker of cell death, 
from THP-1 cells was measured to determine whether pyroptosis is induced by T. 
denticola and Td92. Td92 and T. denticola significantly induced LDH release in 
THP-1 cells, whereas an irrelevant recombinant protein, PP4, had no effect (Fig. 
25A). The LDH release was increased in a dose- and time-dependent manner by 
Td92 stimulation (Fig. 25B and 25C). Approximately 70% cell death was observed 
upon treatment with Td92 for 40 h. LDH release induced by Td92 was decreased in 
the presence of high extracellular K+ (Fig. 25D) or the caspase-1 inhibitors ac-
YVAD-cho and z-YVAD-fmk (Fig. 25E). Pyroptosis is characterized by the 
insertion of pores into the cell membrane, which can be detected by the uptake of a 
low-molecular-weight dye, such as propidium iodide (PI). Td92 increased PI 
uptake in the cells, and this increase was inhibited by the addition of oxATP, KCl, 
or caspase-1 inhibitors (Fig. 25F). Taken together, these results show that Td92 
induces pore formation in the cell membrane and that the cell death is the result of 




Figure 25. Td92 induces pyroptosis, caspase-1-dependent cell death. THP-1 
cells were treated with Td92, live T. denticola, or PP4 for 6 h (A-B). THP-1 cells 
were treated with Td92 (10 µg/ml) for 1 to 40 h (C). THP-1 cells were pretreated 
with KCl, Ac-YVAD-cho, and z-YVAD-fmk for 30 min prior to stimulation with 
Td92 for 6 h (D-E). Cell supernatants were evaluated for the release of the 
cytoplasmic enzyme LDH using the LDH-cytotoxicity assay Kit. Cytotoxicity is 
expressed as the percentage of total LDH released as determined by lysing the cells 
with Triton X-100 detergent. The data are shown as the means ± SD of one 
representative experiment of three performed in triplicate (A-E). *p < 0.01 versus 
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Td92-treated cells (D-E) THP-1 cells were pretreated with oxATP, KCl, Ac-
YVAD-cho, and z-YVAD-fmk for 30 min prior to stimulation with Td92 for 3 h. 
The cells were stained with propidium iodide (PI, 20 μM) and Hoechst 33342 dye 
(10 μM) for 30 min, and images were acquired using fluorescence microscopy. PI-
positive cells were counted out of at least 1000 total cells using the Image J 
software, and the data are presented as the means ± SD of the percentage of PI-
positive cells in one representative experiment of three performed in triplicate. *p < 














3.2.7. Effect of intracellular delivery of Td92 on caspase-1 activation   
Flagellin is one of a few protein ligands that activates caspase-1 in an 
NLRC4-dependent manner, and it must be internalized into the cytosol of the cell 
to exert its activity. To determine whether Td92 internalization is a prerequisite for 
NLRP3 activation, Td92 was delivered into THP-1 cells for 3 and 6 h using a 
transfection reagent Profect P1, which forms non-covalent complexes with proteins 
sized between 10-540 kDa and enables the translocation of intact proteins to cross 
the cell membrane, and caspase-1 activation was analyzed. Unexpectedly, 
internalization decreased the level of caspase-1 activation induced by Td92, 
whereas the intracellular delivery of S. typhimurium flagellin with the transfection 
reagent markedly enhanced caspase-1 activation compared to instances in which 
flagellin was added without the transfection reagent (Fig. 26A). ProIL-1β 
expression induced by Td92 was also decreased by the transfection reagent. An 
increased time for transfection (from 3 to 6 h) did not affect the results. 
Accordingly, the level of IL-1β secretion by Td92-treated cells was remarkably 
reduced by the transfection reagent, whereas flagellin-induced IL-1β secretion was 
increased by the transfection reagent. The enhanced Td92 internalization into the 
cells was confirmed by flow cytometry using FITC-labeled Td92 after extracellular 
fluorescence quenching with trypan blue. For the assay, paraformaldehyde-fixed 
cells, which do not allow endocytic internalization, were used as a negative control. 
The mean fluorescence intensity of the THP-1 cells treated with FITC-labeled 
Td92 was remarkably higher in the presence of Profect P1 than in the absence of 
Profect P1 and increased with time, thereby showing efficient internalization of 
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Td92 into the cells (Fig. 26B, top two panels). To elucidate the relationship 
between Td92 internalization and caspase-1 activation, further experiments were 
tested using cytochalasin D, an inhibitor of actin polymerization, which can delay 
or prevent protein internalization. The pretreatment of THP-1 cells with 
cytochalasin D resulted in a dose-dependent decrease in FITC-labeled Td92 
internalization, when analyzed by flow cytometry (Fig. 26B, bottom panel). 
However, immunoblot analysis showed that cytochalasin D treatment did not affect 
Td92-induced caspase-1 activation, proIL-1β expression, or cell death (Fig. 26C 









Figure 26. Td92 internalization into the cells is not required for caspase-1 
activation or proIL-1β expression. THP-1 cells were stimulated with Td92 or S. 
typhimurium flagellin, which was premixed with or without Profect P1 for 3 and 6 
h. Caspase-1 and IL-1β in the culture supernatants (sup) and procaspase-1, proIL-
1β, and β-Actin in the cell lysates (cell) was detected by immunoblotting (A). THP-
1 cells were incubated with FITC-labeled Td92, which was premixed with or 
without Profect P1 (top two panels), or THP-1 cells were pretreated with 
cytochalasin D for 30 min (bottom panel) before FITC-labeled Td92 treatment for 
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1 or 4 h. Internalization of Td92 was analyzed by flow cytometry. 
Paraformaldehyde-fixed THP-1 cells treated with FITC-Td92 were used as a 
negative control for internalization. The data are presented as the mean 
fluorescence intensities (MFI) from one representative of three independent 
experiments (B). THP-1 cells were pretreated with cytochalasin D for 30 min prior 
to Td92 treatment for 6 h. Caspase-1 and IL-1β in the culture supernatants (sup) 
and procaspase-1, proIL-1β, and β-Actin in the cell lysates (cell) were detected by 














Because S. typhimurium flagellin is known to induce pyroptosis [61], the LDH 
release from the cells treated with Td92 and flagellin was compared in the presence 
or absence of Profect P1 (Fig. 27B). Td92-treated THP-1 cells released 
approximately 17% of the total LDH, and the addition of Profect P1 increased 
LDH release to 25%. Because Profect P1 alone caused release of approximately 
10% of the LDH, the increased LDH release by Td92 plus Profect P1 could be due 
to the mild cytotoxic effect of Profect P1. Flagellin-treated THP-1 cells released 
less than 3% of LDH in the absence of Profect P1, but the addition of Profect P1 
strongly increased the LDH release (26%), indicating that cytosolic flagellin 
efficiently induces caspase-1 activation. These results support the data indicating 
that, unlike flagellin, internalization of Td92 is not critical in activating caspase-1 













Figure 27. Td92 internalization into the cells is not required for cell death. 
THP-1 cells were pretreated with cytochalasin D for 30 min prior to Td92 
treatment for 6 h. LDH released into the culture supernatants was measured (A). 
LDH released into the culture supernatants of Td92- or S. typhimurium flagellin-
stimulated cells with or without the addition of Profect P1 for 6 h (B). The data are 
presented as the means ± SD of one representative experiment of three performed 









3.2.8. Activation of NLRP3 inflammasome by Td92 via interaction with the 
cellular receptor integrin α5β1 
The present results indicate that Td92 binding, not internalization, is important 
for both caspase-1 activation and IL-1β transcription. Profect P1 caused the rapid 
uptake of protein into the cells without binding to the cells, and cytochalasin D 
blocked Td92 internalization without affecting caspase-1 activation and proIL-1β 
expression. It is hypothesized that Td92 binding to a membrane receptor is 
essential for the caspase-1 activation and the transcriptional/posttranscriptional 
regulation of IL-1β. As shown in this study, Td92 was able to bind to KB cells, an 
epithelial cell line, and it contributed to the binding of T. denticola to the cells. 
Additionally, Td92 was able to bind to immobilized fibronectin, which is known to 
be recognized by integrins, including α5β1 and αvβ3. Therefore, to identify the 
cellular receptor for Td92 that is involved in caspase-1 activation, an affinity 
ligand-binding assay was performed using Ni-NTA agarose, which binds histidine-
tagged recombinant Td92. Ni-NTA-bound Td92 was mixed with THP-1 cell 
lysates, and the cellular proteins bound to Td92 were then eluted and subjected to 
immunoblotting with an anti-human fibronectin Ab and an anti-human integrin Abs. 
Because fibronectin was detected only in the culture supernatants of differentiated 
THP-1 cells but not in the cell lysates (Fig. 28), fibronectin was added to the 
ligand-binding assay mixture to test whether Td92 binds to integrin indirectly via 
fibronectin (Fig. 29A, lane 4). Td92 bound to both the α5 and β1 subunits 
(individual subunits) of the integrins, regardless of the presence of fibronectin (Fig. 
29A, lane 4 and 5). The detection of integrin α5β1 in lane 4 was the result of both 
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direct binding of the integrin to Td92 and indirect binding of the integrin to Td92 
via fibronectin. The detection of integrin α5β1 in lane 5 was the result of direct 
binding of Td92 to the integrin. Td92 did not bind directly to the integrin subunits 
αv or β3, but it bound to these integrins in the presence of fibronectin. The 
irrelevant recombinant protein PP4 did not bind to any subunit of the integrins 
(Figure 29A, lane 6). To further assess the specificity of the interaction of Td92 
with the integrin α5β1, the anti-human integrin α5β1 Ab-coated Protein G agarose 
was incubated with recombinant human integrin α5β1 followed by Td92, 
fibronectin, or PP4. Following this experiment, the direct binding of Td92 to 
integrin α5β1 was confirmed by immunoblotting (Fig. 29B, lane 2). Fibronectin 
was used as a positive control and could be detected bound to integrin α5β1 (Fig. 
29B, lane 3), whereas PP4 did not bind to integrin α5β1 (Fig. 29B, lane 4). Td92 
was not detected when it was reacted with the Ab-coated Protein G agarose in the 











Figure 28. Macrophages secrete fibronectin. Expression of fibronectin was 
detected by immunoblotting in the cell lysates (cell) and the supernatants (sup) of 
human PBMC-derived macrophages, PMA-differentiated THP-1 cells (Mф), or 










Figure 29. Integrin α5β1 directly interacts with Td92 to activate caspase-1. (A) 
THP-1 cell lysates (1.4 mg in 100 μl) were reacted with Td92 (50 μg), Td92 
preincubated with fibronectin (Fn, 50 μg), or PP4 (50 μg) while slightly inverting 
at 4°C overnight. The reaction mixtures (300 μl) were incubated with 30 μl of Ni-
NTA agarose at 4°C for 4 h. Agarose-bound proteins were eluted and subjected to 
immunoblotting for the detection of integrin subunits (α5, αν, β1, and β3), 
fibronectin (Fn), Td92, and PP4. (B) Protein G-agarose (20 μg) was incubated with 
an integrin α5β1 Ab (3 μg) at 4°C for 4 h and, subsequently, with recombinant 
human integrin α5β1 (10 μg) at 4°C overnight. After incubating the agarose with 
Td92 (10 μg), fibronectin (Fn, 20 μg), or PP4 (10 μg) at 4°C overnight, the proteins 
bound to the integrin α5β1-coated agarose were analyzed by immunoblotting using 
a histidine Ab (for the detection of recombinant Td92 and PP4), a fibronectin Ab or 
an integrin α5 Ab. 
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Using a polyclonal integrin β1 Ab, the β1 subunit of integrins from THP-1 
cells was detected as two distinct bands, which were recognized by both Td92 and 
fibronectin. The β1 integrin undergoes variable glycosylation according to cell type 
[62]. Indeed, the deglycosylation of THP-1 cell lysates using N-glycosidase F, 
which cleaves between the innermost N-acetylglucosamine and asparagine residues 
of oligosaccharides from N-linked glycoproteins, resulted in a single β1 integrin 
form that had a decreased molecular mass (approximately 95-kDa) when analyzed 
by immunoblotting (Fig. 30A), suggesting that the molecular mass difference in the 
two forms of β1 integrin may be completely attributed to the levels of 
glycosylation. Lysates of THP-1 cells treated with tunicamycin, which inhibits N-
glycosylation of newly synthesized glycoproteins, were reacted with Ni-NTA-
bound Td92, and the cellular proteins bound to Td92 were detected by 
immunoblotting with an anti-human integrin β1 Ab. Td92 binding to the 
unglycosylated form of β1 integrin was not observed (Fig. 30B), indicating that 
inhibition of glycosylation of integrin α5β1 affects the binding of Td92. Although 
Td92 and fibronectin recognized both forms of β1 integrin, the lower band of β1 
integrin was preferentially pulled down over the upper band. As a control, 
recombinant integrin αvβ3 was included. Integrin αvβ3 Ab-coated Protein G 
agarose was incubated with recombinant human integrin αvβ3 and subsequently 
with Td92, fibronectin, or PP4. Td92 and PP4 were not found to bind integrin αvβ3 
(Fig. 31), whereas fibronectin did bind integrin αvβ3, suggesting specific 






Figure 30. Td92 does not bind to unglycosylated integrin β1. THP-1 cell lysates 
(10 μg or 20 μg) were incubated with 1 unit of N-glycosidase F and subjected to 
SDS-PAGE followed by immunoblotting using an integrin β1 Ab and biotinylated 
Phaseolus vulgaris Leucoagglutinin (PHA-L) (A). THP-1 cells were treated with 1 
μg/ml tunicamycin during differentiation with PMA for additional 6 h before lysis. 
THP-1 cell lysates (1.4 mg in 100 μl) were reacted with Td92 (50 μg), Td92 
preincubated with fibronectin (Fn, 50 μg), or PP4 (50 μg) while slightly inverting 
the reaction mixture at 4°C overnight. The reaction mixtures (300 μl) were 
incubated with 30 μl of Ni-NTA agarose at 4°C for 4 h. Agarose-bound proteins 








Figure 31. Integrin αvβ3 does not interact with Td92. Protein G-agarose (20 μg) 
was incubated with an integrin αvβ3 Ab (3 μg) at 4°C for 4 h and then with 
recombinant human integrin αvβ3 (10 μg) at 4°C overnight. After incubating the 
agarose with Td92 (10 μg), fibronectin (Fn, 20 μg), or PP4 (10 μg) at 4°C 
overnight, the proteins bound to the integrin αvβ3-coated agarose were analyzed by 
immunoblotting using a histidine Ab (for the detection of recombinant Td92 and 
PP4), a fibronectin Ab, or an integrin αν Ab (The heavy and light chains of the 






Ligand binding of the integrin receptor induces clustering of the integrins and 
recruitment of focal adhesion-associated proteins. To assess the formation of 
integrin α5β1 clustering upon Td92 binding, THP-1 cells were treated with Td92, 
fibronectin (a positive control), or bovine serum albumin (BSA, a negative control) 
at different times and observed by confocal microscopy after staining with an 
integrin α5β1 Ab and a Cy3-labeled secondary antibody. A uniform distribution of 
integrin α5β1 was observed in unstimulated cells (Fig. 32). However, upon 
stimulation of THP-1 cells with Td92 or fibronectin, extensive aggregation of 
integrin α5β1 on the cell surface was observed in more than 80% of the cells after 
15 min, whereas the BSA treatment did not induce integrin aggregation over the 
time course up to 2 h. Because cytochalasin D prevented Td92 internalization, 
THP-1 cells were pretreated with cytochalasin D prior to FITC-labeled Td92 
treatment to visualize Td92 binding to integrin α5β1. Upon incubating the THP-1 
cells with Td92 for up to 2 h, the colocalization of Td92 with integrin α5β1 was 
clearly observed, whereas without cytochalasin D pretreatment, Td92 was observed 
in the cells as well as on the cell surface (Fig. 33). To validate these data that 
showing the involvement of integrin α5β1 in Td92-induced caspase-1 activation, an 
experiment was performed with integrin siRNA. Because the intact integrin α5 is 
known to be essential for α5β1 dimer formation, expression on the cell surface, and 
its biological function [63], siRNA specific for integrin α5 was used. Caspase-1 
activation and proIL-1b expression induced by Td92 were remarkably inhibited in 






Figure 32. Td92 binding to the cells induces integrin clustering. THP-1 cells 
were treated with Td92, fibronectin (Fn), or heat-inactivated BSA for 15, 60, and 
120 min. After washing, the cells were fixed with 3.8% paraformaldehyde in PBS 
and immunostained using an integrin α5β1 Ab and a Cy3-conjugated secondary Ab. 
Cells were analyzed by confocal laser scanning microscopy. A representative cell 






Figure 33. Colocalization of Td92 with integrin α5β1 is clearly observed with 
or without cytochalasin D. THP-1 cells cultured on a cover glass were pretreated 
with cytochalasin D for 30 min and then incubated with FITC-labeled Td92 (10 
μg/ml) for 2 h. After fixation with 3.8% paraformaldehyde in PBS, the cells were 
incubated with an integrin α5β1 Ab followed by a Cy3-conjugated secondary Ab 
with the nuclear staining with Hoechst 33342 and were observed by confocal 









Figure 34. Knockdown of integrin α5 affects Td92-induced inflammasome 
activation. THP-1 cells were transfected with α5 siRNA or control siRNA for 36 h. 
To confirm RNA interference, the cells were used for RNA extraction followed by 
real-time qPCR. Also, siRNA-transfected cells were treated with Td92, Caspase-1 
and IL-1β in the culture supernatants (sup) and proIL-1β, β-Actin, and integrin α5 
in the cell lysates (cell) were detected by immunoblotting. The real-time qPCR data 
are shown as the means ± SD of one representative experiment of three performed 
in triplicate. The band intensities on the immunoblots were quantified using NIH 
Image J software and are presented as the relative ratio to β-Actin. *p < 0.05 versus 




To further confirm that Td92 bound to the cells via integrin α5β1, a 
neutralizing integrin α5β1 Ab was used. The integrin α5β1 Ab inhibited FITC-
labeled Td92 binding to THP-1 cells as analyzed by flow cytometry (Fig. 35A). 
Although the integrin α5β1 Ab did not completely inhibit Td92 binding to the cells, 
we observed that the antibody inhibited Td92 binding in a dose-dependent manner 
and that more than 60% of Td92 binding was inhibited at a concentration of 25 
μg/ml of the antibody (Fig. 35B), suggesting integrin α5β1 is the major cellular 
















Figure 35. Integrin α5β1 Ab inhibits FITC-Td92 binding to THP-1 cells. THP-
1 cells were incubated with an integrin α5β1 Ab (10 and 20 μg/ml: A; 5 to 25 
μg/ml: B) or the anti-mouse IgG1 isotype control (10 μg/ml: A; 25 μg/ml: B) for 1 
h prior to incubation with FITC-labeled Td92 (10 μg/ml) for 30 min, and Td92 
binding was analyzed by flow cytometry. The data are presented as the mean 






In addition, the integrin α5β1 Ab remarkably reduced caspase-1 activation and 
IL-1β secretion in a dose-dependent manner (Fig. 36A and 36B), whereas a 
neutralizing integrin αvβ3 Ab did not affect Td92 binding to cells, caspase-1 
activation, or IL-1β secretion (Fig. 37). Td92-induced caspase-1 activation and 
proIL-1β expression in THP-1 cells pretreated with cytochalasin D were inhibited 
by the integrin α5β1 Ab (Fig. 38). These results confirm that Td92 internalization 
is not required for these mechanisms. The integrin α5β1 Ab also significantly 
reduced T. denticola-induced IL-1β secretion. The addition of the integrin α5β1 Ab 
at 2, 5, 10, and 20 μg/ml reduced the level of T. denticola-induced IL-1β secretion 
by 12, 17, 36, and 45% compared with the same concentration of IgG1 isotype Ab 
(Fig. 39D). The level of proIL-1β transcription was also reduced by the integrin 
α5β1 Ab (Fig. 36A). Additionally, neutralizing effects of the integrin α5β1 Ab on 
native Td92 and T. denticola whole bacteria–induced caspase-1 activation and 
proIL-1β expression were observed (Fig. 39A and 39B). However, the integrin 










Figure 36. Integrin α5β1 Ab inhibits Td92-induced inflammasome activation. 
THP-1 cells were pretreated with an integrin α5β1 Ab (2 to 20 μg/ml) or the anti-
mouse IgG1 isotype control (10 μg/ml) for 1 h prior to stimulation with Td92 (10 
μg/ml) for 6 h (A-B). Caspase-1 and IL-1β in the culture supernatants (sup) and 
procaspase-1, proIL-1β, and β-Actin in the cell lysates (cell) were detected by 
immunoblotting (A), and the IL-1β level in the culture supernatants was measured 
by ELISA (B). The band intensities on the immunoblots were quantified using NIH 
Image J software and are presented as the relative ratio to β-Actin (A). The data are 
shown as the mean ± SD of one representative experiment of three performed in 





Figure 37. Integrin αvβ3 is not involved in Td92-induced NLRP3 activation. 
THP-1 cells were pretreated with an anti-human integrin αvβ3 Ab (10 and 20 
μg/ml) or the anti-mouse IgG1 isotype control (10 μg/ml) for 1 h prior to incubation 
with FITC-labeled Td92 (10 μg/ml) for 30 min, and Td92 binding was analyzed by 
flow cytometry. The data are presented as the mean fluorescence intensities (MFI) 
from one representative of three independent experiments (A). THP-1 cells were 
pretreated with an anti-human integrin αvβ3 Ab (2 to 10 μg/ml) or the anti-mouse 
IgG1 isotype control (10 μg/ml) for 1 h prior to stimulation with Td92 for 6 h (B-C). 
Caspase-1 and IL-1β in the culture supernatants (sup) and procaspase-1, proIL-1β, 
and β-Actin in the cell lysates (cell) were detected by immunoblotting (B), and the 
IL-1β level in the culture supernatants was measured by ELISA (C). The data are 
shown as the means ± SD of one representative experiment of three performed in 





Figure 38. Td92-induced caspase-1 activation and proIL-1β expression in 
THP-1 cells pretreated with cytochalasin D are inhibited by an integrin α5β1 
Ab. THP-1 cells were pretreated with cytochalsin D for 30 min and subsequently 
with an integrin α5β1 Ab for 1 h before treatment of the cells with Td92 for 6 h. 
Caspase-1 and IL-1β secreted into the culture supernatants (sup) and procaspase-1, 









Figure 39. Integrin α5β1 is involved in caspase-1 activation by native Td92 
and T. denticola, but not by flagellin. THP-1 cells were pretreated with an anti-
human integrin α5β1 Ab (2 to 10 μg/ml: A-C; 2 to 20 μg/ml: D) or the anti-mouse 
IgG1 isotype control (10 μg/ml: A-C; 2 to 20 μg/ml: D) for 1 h prior to stimulation 
with native and recombinant Td92 (10 μg/ml), live T. denticola (MOI 1000), or S. 
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typhimurium flagellin (500 ng/ml) for 6 h. S. typhimurium flagellin was premixed 
with Profect P1 before cell stimulation. Caspase-1 and IL-1β in the culture 
supernatants (sup) and procaspase-1, proIL-1β, and β-Actin in the cell lysates (cell) 
were detected by immunoblotting (A-B). The IL-1β level in the culture 
supernatants was analyzed by ELISA. The data are shown as the mean ± SD of one 
representative experiment of three performed in triplicate. *p < 0.05 versus 














To test that integrin α5β1 was also involved in Td92-induced caspase-1 
activation in PBMC-derived macrophages, freshly isolated PBMCs were 
differentiated into macrophages and stimulated with Td92. Td92 induced caspase-1 
activation and IL-1β secretion, and the integrin α5β1 Ab markedly reduced 
caspase-1 activation and IL-1β secretion by Td92 in PBMC-derived macrophages 
(Fig. 40). In contrast to the findings in THP-1 cells, proIL-1β expression in 
untreated PBMC-derived macrophages was similar to that in Td92-treated cells, 













Figure 40. Td92 induces IL-1β secretion in human PBMC-derived 
macrophages. Human PBMC-derived macrophages were pretreated with an 
integrin α5β1 Ab (2 to 20 μg/ml) or the anti-mouse IgG1 isotype control (10 μg/ml) 
for 1 h prior to stimulation with Td92 (10 μg/ml) for 6 h. Caspase-1 and IL-1β in 
the culture supernatants (sup) and procaspase-1, proIL-1β, and β-Actin in the cell 
lysates (cell) were detected by immunoblotting (A). The IL-1β level in the culture 
supernatants was analyzed by ELISA. The data are shown as the mean ± SD of one 
representative experiment of three performed in triplicate. *p < 0.05 versus 




Because Td92-induced ATP is a critical factor in NLRP3 inflammasome 
activation by Td92, the effect of the integrin α5β1 Ab on Td92-induced ATP 
production was analyzed. The antibody reduced the release of ATP by Td92 to the 
control level (Fig. 41). The neutralizing fibronectin Ab did not affect caspase-1 
activation, proIL-1β expression, or IL-1β secretion, although the binding of Td92 
was reduced by the addition of the fibronectin Ab (Fig. 42). The binding of Td92 to 
soluble and immobilized fibronectin was confirmed by ELISA using FITC-labeled 
Td92 and fibronectin (Fig. 43). The FITC-labeled fibronectin in solution was 
bound to immobilized Td92, and non-labeled fibronectin competed with FITC-
labeled fibronectin to bind Td92. FITC-labeled Td92 also bound to immobilized 
fibronectin, and the RGD peptide (GRGDSP) did not interfere with the binding of 
Td92 to fibronectin. These results indicate that although Td92 is able to bind to 
both integrin α5β1 and fibronectin, Td92-induced NLRP3 activation is mediated 
via direct binding to integrin α5β1, but not by binding to fibronectin, indicating that 
the interaction between Td92 and integrin α5β1 plays a critical role for NLRP3 








Figure 41. Integrin α5β1 is involved in ATP release by Td92. THP-1 cells were 
pretreated with an integrin α5β1 Ab (10 and 20 μg/ml) or the anti-mouse IgG1 
isotype control (10 μg/ml) for 1 h before stimulation with Td92 (10 µg/ml) for 2 h. 
Extracellular ATP levels were determined using an ATP bioluminescence assay Kit. 
The data are shown as the means ± SD of one representative experiment of three 









Figure 42. Td92 binding to fibronectin does not affect caspase-1 activation. 
THP-1 cells were pretreated with a fibronectin Ab (10 and 20 μg/ml) or the anti-
mouse IgG1 isotype control (10 μg/ml) for 1 h prior to incubation with FITC-
labeled Td92 (10 μg/ml) for 30 min, and the Td92 binding was analyzed by flow 
cytometry. The data are presented as the mean fluorescence intensities (MFI) of 
one representative of three independent experiments (A). THP-1 cells were 
pretreated with a fibronectin Ab (2 to10 μg/ml) or the anti-mouse IgG1 isotype 
control (10 μg/ml) for 1 h prior to stimulation with Td92 for 6 h (B-C). Caspase-1 
and IL-1β secreted in the culture supernatants (sup) and procaspase-1, proIL-1β, 
and β-Actin in the cell lysates (cell) were detected by immunoblotting (B). The IL-
1β level in the culture supernatants was measured by ELISA. The data are 
presented as the means ± SD of one representative experiment of three performed 




Figure 43. Td92 binds to soluble and immobilized fibronectin. Ninety-six well 
microtiter plates were coated with 100 μl of Td92 (10 μg/ml) or skim milk (5 
μg/ml). FITC-labeled fibronectin (1 to 20 μg/ml) was added to the wells at 37°C 
for 1 h (A). FITC-labeled fibronectin (10 μg/ml) was added in the presence of non-
labeled fibronectin (1 to 10 μg/ml) (B). Ninety-six well microtiter plates were 
coated with 100 μl of human plasma fibronectin (10 μg/ml) or skim milk. FITC-
labeled Td92 (0.5 to 10 μg/ml) was added to the wells at 37°C for 1 h (C). The 
RGD peptide was added to the wells for 30 min prior to the addition of FITC-
labeled Td92 (5 μg/ml) for 1 h (D). The fluorescence of fibronectin bound to Td92 
and Td92 bound to immobilized fibronectin was measured with a fluorometer. *p < 
0.01 versus the control in each experiment (no addition of FITC-labeled fibronectin 
in A; no addition of non-labeled fibronectin in B; no addition of FITC-labeled 
Td92 in C) 
119 
 
To determine whether the priming of integrin α5β1 by other ligands induces 
NLRP3 activation, THP-1 cells were treated with representative integrin α5β1 
ligands, such as fibronectin (a soluble form) and the RGD peptide (GRGDSP), and 
the ligands were analyzed for their ability to activate caspase-1. Fibronectin (5-20 
μg/ml) and the RGD peptide (10 and 100 μg/ml) induced caspase-1 activation 
without the addition of ATP, whereas the non-RGD peptide (GRADSP) did not 
induce caspase-1 activation (Fig. 44A). The addition of ATP did not affect caspase-
1 activation by fibronectin or the RGD peptide (Fig. 44B). As expected, fibronectin 
and the RGD peptide significantly induced the release of ATP in THP-1 cells (Fig. 
45). The addition of the integrin α5β1 Ab or oxATP markedly inhibited the 
caspase-1 activation induced by fibronectin or the RGD peptide (Fig. 46A and 
46B). However, an integrin αvβ3 Ab did not inhibit caspase-1 activation by 
fibronectin (Fig. 47). Neither fibronectin nor the RGD peptide induced proIL-1β 
expression at the concentrations used in this study (Fig. 44A).   
Taken together, the results above confirm that integrin α5β1 is the principle 
receptor for NLRP3 activation, and ATP is the primary regulator. Because there is 
no RGD motif in Td92, the Td92 binding site for integrin α5β1 is most likely 
distinct from that of fibronectin and, possibly, that of other RGD-containing 
proteins. The interaction between Td92 and integrin α5β1 is similar to the 
interaction between fibronectin/RGD and integrin α5β1 in terms of caspase-1 





Figure 44. Priming of integrin α5β1 by other ligands induces NLRP3 
activation. THP-1 cells were treated with fibronectin (Fn, 5 to 20 μg/ml), 
GRGDSP peptide (10 and 100 μg/ml), GRADSP peptide (10 and 100 μg/ml), Td92 
(10 μg/ml), or PP4 (10 μg/ml) for 6 h (A). THP-1 cells were treated with 
fibronectin or Td92 (10 μg/ml) for 6 h. In some experiments, Fn-stimulated cells 
were pulsed with 2.5 mM ATP for 30 min and the Td92-stimulated cells were 
pretreated with oxATP (300 μM) for 30 min before stimulation with Td92 for 6 h 
(B). Caspase-1 and IL-1β in the culture supernatants (sup) and procaspase-1, 






Figure 45. Integrin α5β1 ligands induce extracellular ATP release. 
Extracellular ATP levels were determined in the supernatants of fibronectin (Fn)-, 
GRGDSP-, GRADSP-, or Td92-incubated cells for 2 h. The data are shown as the 
means ± SD of one representative experiment of three performed in triplicate. *p < 











Figure 46. Interaction between Fibronectin/RGD and integrin α5β1 induces 
NLRP3 activation. THP-1 cells were pretreated with an integrin α5β1 Ab (4 and 
10 μg/ml) or the anti-mouse IgG1 isotype control (10 μg/ml) for 1 h (A) or oxATP 
(300 and 500 μM) for 30 min (B) prior to stimulation with fibronectin (Fn), 
GRGDSP, or Td92 for 6 h. Caspase-1 in the culture supernatants (sup) and 








Figure 47. The integrin ανβ3 Ab does not inhibit fibronectin-induced caspase-
1 activation. THP-1 cells were pretreated with an integrin ανβ3 Ab (4 and 10 
μg/ml) or the anti-mouse IgG1 isotype control (10 μg/ml) for 1 h prior to 
stimulation with fibronectin (Fn) for 6 h. Caspase-1 in the culture supernatants 











3.2.9. NF-κB activation by Td92 for the proIL-1β expression and NLRP3 
activation  
These results suggest that the binding of Td92 to cell membrane integrin α5β1 
is a critical step for NLRP3 inflammasome activation via ATP release, which 
causes K+ efflux. Because anti-human integrin α5β1 Ab also reduces the expression 
of proIL-1β induced by Td92, NF-κB and MAP kinase inhibitors were used to 
determine whether these signaling pathways are involved in proIL-1β expression 
following Td92 binding to integrin. The induction of proIL-1β expression by Td92 
was inhibited by pretreatment of the cells with inhibitors of NF-κB (TPCK and 
BAY-117082) and MAP kinases, including p38 (SB202190 and SB203580), ERK 
(PD98059), and JNK (SP600125) (Fig. 48A). Pretreatment of the cells with the 
integrin α5β1 Ab markedly inhibited IκBα degradation and reduced the 
phosphorylation of p38, ERK, and JNK (Fig. 48B). NF-κB translocation into the 
nucleus using NF-κB p65 Ab was observed by confocal microscopy in the cells 
treated with Td92, T. denticola, LPS (a positive control), or TNF-α (a positive 
control). PP4, used as a negative control, did not induce NF-κB translocation (Fig. 
49A). To assess the inhibitory effect of the integrin α5β1 Ab and oxATP, the 
number of cells with NF-κB translocation were counted following pretreatment of 
THP-1 cells with the integrin α5β1 Ab for 1 h or oxATP for 30 min prior to 
treatment with Td92 or T. denticola for 1 h. The integrin α5β1 Ab and oxATP 
significantly reduced the induction of NF-κB translocation by Td92 or T. denticola, 
but not by LPS (Fig. 49B and C). The integrin α5β1 Ab and oxATP did not inhibit 





Figure 48. NF-κB and MAP kinase signaling pathways are involved in proIL-
1β expression following Td92 binding to integrin. THP-1 cells were pretreated 
with various inhibitors (Lanes: 3, SB202190 20 μM; 4, SB203580 30 μM; 5, TPCK 
30 μM; 6, BAY-117082 10μM; 7, SP600125 20 μM; 8, PD98059 50 μM) for 30 
min prior to stimulation with Td92 for 6 h. IL-1β in the culture supernatants (sup) 
and proIL-1β and β-Actin in the cell lysates (cell) were detected by 
immunoblotting (A). THP-1 cells were pretreated with an integrin α5β1 Ab (10 
μg/ml) or the anti-mouse IgG1 isotype control (10 μg/ml) for 1 h prior to 
stimulation with Td92 for 30 min. The cell lysates were subjected to 








Figure 49. Td92 and T. denticola binding to integrin α5β1 induces NF-κB 
translocation. THP-1 cells were stimulated with Td92, T. denticola, LPS, TNF-α, 
or PP4 for 1 h, and NF-κB localization was detected using a NF-κB p65 Ab and a 
Cy3-conjugated secondary Ab with nuclear staining with Hoechst 33342 (A-C). 
NF-κB translocation into the nucleus of the cells was observed using confocal laser 
scanning microscopy (A). The number of cells positive for NF-κB activation after 
pretreatment with the integrin α5β1 Ab (B, 10 μg/ml) or oxATP (C, 300 μM) was 
counted out of a total of at least 500 cells with the NIH Image J software, and the 
data are presented as the means ± SD of one representative experiment of three 
performed in triplicate. *p < 0.05 versus unstimulated cells; #p < 0.01 versus Td92 






Figure 50. Integrin α5β1 Ab and oxATP did not affect LPS-induced proIL-1β 
expression. THP-1 cells were pretreated with an integrin α5β1 Ab (4 and 10 
μg/ml), the anti-mouse IgG1 isotype control (10 μg/ml), or oxATP (300 μM) for 30 
min (B) or 1 h (A) prior to stimulation with LPS or Td92 for 6 h. ProIL-1β and β-








Because the integrin α5β1 Ab and oxATP reduced both the caspase-1 
activation and the proIL-1β expression induced by Td92 and because the NF-κB 
pathway has an important role in Td92-induced proIL-1β expression, the NF-κB 
pathway was tested for its involvement in the Td92-induced caspase-1 activation. 
As shown in Fig. 51A, Td92-induced caspase-1 activation was reduced by a 
specific NF-κB inhibitor, Bay-117082, suggesting a key role of NF-κB for IL-1β 
production and secretion. Proinflammatory stimuli, including TLR ligands (LPS, 
Pam3CSK4, and poly(I:C)) and TNF-α, have been reported to induce NLRP3 
expression, which is thought to be a limiting factor for NLRP3 activation and to be 
mediated by NF-κB activation [64]. Td92 induced NLRP3 expression, and this was 
inhibited by an NF-κB inhibitor that was also tested. Td92 induced NLRP3 
expression at the gene (Fig. 51B) and protein (Fig. 51C) levels, and this induction 
was inhibited by the specific NF-κB inhibitor Bay-117082. Td92-induced NLRP3 
expression was also reduced by incubation with an integrin α5β1 Ab or oxATP 
(Fig. 51C). These results indicate that Td92 fulfills all of the requirements for the 
activation of the NLRP3 inflammasome and IL-1β secretion by priming the cell 
through integrin α5β1 and NF-κB activation. Marginal upregulation of NLRP3 
expression was observed when the cells were treated with fibronectin (Fig. 51C). 
Although TLR4 is not involved in Td92-induced proIL-1β expression, further 
experiments were performed to determine whether any TLRs could be primed with 
Td92 to induce NF-κB activation and proIL-1β expression. Because TLR signaling 
is transmitted through the adaptor proteins myeloid differentiation factor 88 
(MyD88) and/or Toll/IL-1 receptor domain-containing adapter inducing interferon-
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β (TRIF) to activate NF-κB, the THP-1 cells transfected with siRNA specific for 
MyD88 or TRIF were treated with Td92 or LPS. MyD88 or TRIF knockdown 
significantly inhibited LPS-induced NF-κB translocation into the nucleus, but it did 
not affect Td92-induced NF-κB translocation (Fig. 52A). To examine the effect of 
MyD88 or TRIF knockdown on Td92-induced proIL-1β expression, the effect of 
the knockdown of these genes on Td92-induced proIL-1β expression was also 
observed. Td92-induced proIL-1β expression was not changed by MyD88 or TRIF 
knockdown, whereas LPS-induced proIL-1β expression was markedly decreased 
(Fig. 52B). These results exclude the involvement of any TLRs in Td92-induced 












Figure 51. Priming of the cells by Td92 through integrin α5β1 and NF-κB 
activation fulfills the activation of NLRP3 inflammasome. THP-1 cells were 
pretreated with Bay-117082 for 30 min before stimulation with Td92 and LPS for 6 
h. LPS-stimulated cells were pulsed with 2.5 mM ATP for 30 min. Caspase-1 and 
IL-1β in the culture supernatants (sup) and procaspase-1, proIL-1β, and β-Actin in 
the cell lysates (cell) were detected by immunoblotting (A). THP-1 cells were 
stimulated with Td92 or LPS for 4 h. The cells were subjected to RNA extraction 
followed by real-time qPCR to detect NLRP3 mRNA expression. The real-time 
qPCR data are shown as the means ± SD of one representative experiment of three 
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performed in triplicate (B). THP-1 cells were pretreated with an integrin α5β1 Ab 
(10 μg/ml), the anti-mouse IgG1 isotype control (10 μg/ml), Bay-117082 (Bay, 10 
μM), or oxATP (Ox, 300 μM) for 30 min or 1 h prior to stimulation with Td92 (10 
μg/ml) for 6 h. The cells were subjected to immunoblotting for the detection of 
NLRP3 expression. Fibronectin (Fn, 10 μg/ml)-stimulated cells were also included 




Figure 52. Knockdown of MyD88 or TRIF does not affect Td92-induced NF-
κB activation and proIL-1β expression. The THP-1 cells transfected with 
MyD88 or TRIF siRNA were treated with Td92 or LPS for 1 h, and NF-κB 
localization was detected using a NF-κB p65 Ab and a Cy3-conjugated secondary 
Ab with nuclear staining with Hoechst 33342. NF-κB translocation into the nucleus 
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of the cells was observed by confocal microscopy. The number of cells positive for 
NF-κB activation was counted out of a total of at least 500 cells using the NIH 
Image J software, and the data are presented as the means ± SD of one 
representative experiment of three performed in triplicate. *p < 0.05 versus 
unstimulated cells; #p < 0.01 versus control siRNA-transfected cells Scale bars 
represent 50 μm (A). The THP-1 cells transfected with MyD88 or TRIF siRNA 
were treated with Td92 or E. coli LPS for 6 h. Knockdown of MyD88 and TRIF by 
siRNA and the expression of proIL-1β, MyD88, TRIF, and β-Actin in cell lysates 
were detected by immunoblotting. The band intensities on the immunoblots were 













Microbial genome projects have unraveled the genome sequences of an 
expanding number of pathogens, including major oral pathogens [1], and the 
comparison of genes between bacterial species allows for the determination of gene 
function by amino acid similarity and conserved functional domains. The 
information on bacterial genome sequences facilitates the elucidation of bacterial 
physiology, biosynthesis and metabolic pathways. With comparative genomics, it 
is also possible to determine the virulence factors involved in pathogenesis. The 
enormous diversity of oral treponemes, even within a single periodontitis patient, 
has been a roadblock to the study of their common pathogenicity. Recently, the 
whole genome sequence of T. denticola, the most intensively studied oral 
spirochete, has been deciphered [65]. Genomic information is being used to search 
for conserved surface antigens present in representative oral spirochetes associated 
with periodontitis and to examine their functional roles, thus leading to insights on 
a common pathogenesis that would be useful for developing of a strategy for 
growth inhibition or eradication. Identification and functional analysis of conserved 
OMPs are therefore important for understanding the common mechanisms of 
pathogenesis in the extremely diverse collection of oral spirochetes. In this study, 
highly conserved surface antigens of oral spirochetes that are homologous to Tp92 
with an opsonic potential in T. pallidum [18] were identified and characterized for 
their virulence. The Tp92 homologs from oral spirochetes showed high homology 
with Tp92, and the antibody raised against Td92, a Tp92 homolog of T. denticola, 
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cross-reacted with the Tp92 homologs of T. lecithinolyticum, T. maltophilum, and 
T. socranskii subsp. socranskii. Td92 is an outer membrane protein with a surface-
exposed epitope that could be detected using a Td92 Ab. The fact that anti-Td92 
recognized other Treponema species included in this study suggests that the Tp92 
homologs from oral spirochetes share a similar surface structural motif.  
In spite of high homology with Tp92, the Tp92 homologs of oral spirochetes 
have distinct characteristics. First, the Tp92 homologs of oral spirochetes have no 
serine-rich region at the C-terminal, which is a signature sequence in the T. 
pallidum Tp92. The C-terminus of Tp92 encompassing the serine repeat signature 
sequence (245 aa) was not expressed in E. coli. However, the full length tp92 gene 
homologs of oral spirochetes were expressed in E. coli, showing the expected 
molecular masses. Second, the calculated pI of the Tp92 homologs was different 
from that of Tp92. The pI of the Tp92 homologs was in the acidic range between 
5.46-6.34, while the pI of Tp92 was 8.27. Third, a cysteine residue is absent in the 
Tp92 homologs of oral spirochetes, and only one is present in the case of T. 
lecithinolyticum and T. maltophilum, while three cysteine residues are present in 
Tp92, implying the possible formation of an intramolecular disulfide bond. It will 
be interesting to examine whether these differences are linked to distinct functions. 
T. denticola, along with Porphyromonas gingivalis and Tannerella forsythia, 
belongs to the red cluster according to the classification by Socransky et al. [3], 
who defined bacterial groups in dental plaque biofilms with respect to their 
reciprocal association and sequential formation. The red complex produces 
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significant amounts of proteases, including trypsin-like peptidase activity, and is in 
contact with the gingival junctional epithelium. In this study, it has been observed 
that the Tp92 homologs adhered to epithelial cells, suggesting that the encoded 
proteins mediate the binding of Treponema cells to host cells and thus accelerate 
their pathologic effects. Several surface proteins of T. denticola have been reported 
to attach to host cells or extracellular matrix (ECM) proteins. The best studied of 
proteinis the 53-kDa Msp, which is able to bind epithelial cells, fibroblasts and 
ECM proteins, such as fibronectin, keratin, laminin, collagen, fibrinogen, 
hyaluronic acid, and heparin [13, 66]. CTLP has been demonstrated to bind to PDL 
epithelial cells [6] and to P. gingivalis fimbriae, implicating it in the coaggregation 
of T. denticola and P. gingivalis [67]. The leucine-rich repeat protein LrrA has 
been demonstrated to attach to human epithelial cells [68]. OppA (70 kDa) bound 
soluble plasminogen and fibronectin [14]. In the present study, Td92 significantly 
inhibited T. denticola adhesion to epithelial cells. This fact suggests that Td92 is a 
T. denticola adhesin.  
The Tp92 homologs upregulated IL-1β, TNF-α, IL-6, IL-8, PGE2, and MMP-9 
in THP-1 cells. These factors are proinflammatory and osteoclastogenic factors, 
and they have been reported to be stimulated by periodontopathogens, including 
the red complex. IL-1β and TNF-α are representative proinflammatory cytokines 
associated with periodontal disease characterized by a loss of connective tissue 
attachment and bone resorption, leading to alveolar bone loss [69]. IL-1β is a 
potent stimulator of bone resorption and an inhibitor of bone formation that 
enhances osteoclast differentiation and acts as a survival factor for mature 
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osteoclasts [27, 70, 71]. It has been shown to activate RANKL in PDL cells [72]. 
TNF-α promotes the production of RANKL and macrophage colony-stimulating 
factor by stromal cells and induces osteoclast formation. In experimental 
periodontitis, IL-1 and TNF antagonists have been demonstrated to inhibit the 
inflammatory response and bone loss [69]. IL-6, together with IL-1β and TNF-α, is 
a major mediator of the host response to tissue destruction and bone resorption. IL-
6 binds to its receptor, existing in either a membrane-bound form (CD126) or a 
soluble form (sIL-6R alpha). This complex subsequently binds to a signal 
transducing protein, gp130 [73], leading to upregulation of RANKL in osteoblasts, 
which is a key factor in osteoclastogenesis. IL-8 is a representative chemokine and 
leads inflammatory cells to infection sites, playing an important role in initiating 
the inflammatory reactions. PGE2 stimulates osteoclastogenesis through 
stimulation of RANKL production, inhibition of osteoprotegerin secretion by 
osteoblasts, and stimulation of IL-6 production [74, 75]. PGE2 was synergistically 
stimulated by IL-1 and TNF in human gingival fibroblasts [76]. MMP-9 is a zinc-
dependent proteinase and has been demonstrated to play an important role in the 
bone resorption process by dissolving the bone matrix, releasing the chemotactic 
factor on osteoclasts, and activating the cytokines involved in bone resorption [77]. 
Although various periodontopathogens have been shown to induce all these host 
factors, only a few bacterial factors have been identified at the molecular level. 
LPS is a prominent molecule that induces proinflammatory cytokines and bone 
resorbing factors. LPS or LPS-like molecules of periodontopathogens have been 
demonstrated to modulate biological activities, including the upregulation of IL-1, 
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TNF-α, IL-6, IL-8, PGE2 and MMP-9 in various host cell types [78-81]. These 
factors are found at significantly higher levels in the tissues and GCF of 
periodontitis patients than those of in healthy subjects [82, 83]. Among surface 
proteins, the outer membrane protein 100 of Aggregatibacter (Actinobacillus) 
actinomycetemcomitans and fimbrillin of P. gingivalis (41 and 67 kDa) have been 
demonstrated to induce proinflammatory cytokines in host cells, including 
epithelial cells and macrophages [84-86]. The 67-kDa P. gingivalis fimbriae 
protein induced osteoclast differentiation, and blocking of IL-1, TNF and IL-6 
induced by the protein reduced osteoclast differentiation. Recently, it has been 
reported that the major surface protein MspTL of T. lecithinolyticum induced IL-1β, 
TNF-α, IL-6 and PGE2 in THP-1 cells [15, 45]. Although the Tp92 homologs are 
not abundant surface proteins, such as Msp of T. denticola and MspTL of T. 
lecithinolyticum, when judged by SDS-PAGE profiles, they are widely distributed 
in oral spirochetes, and the coexistence of various species of oral spirochetes in a 
single patient or at a single site may result in the amplification of the 
cytopathological effects on host cells.  
In this study, it has been demonstrated that the direct interaction of integrin 
α5β1 and T. denticola Td92, which is a bacterial surface protein of a 
periodontopathogen, induces NLRP3 activation in THP-1 cells and PBMC-derived 
macrophages, which have been well characterized in terms of inflammasome 
activation [56, 57]. Td92-induced caspase-1 activation caused pyroptosis, an 
inflammatory cell death. Although integrins are not conventional pathogen 
recognition receptors, as are TLRs, retinoic acid inducible gene I, NLRs, and C-
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type lectins, many pathogens directly or indirectly exploit integrin α5β1 for 
adherence and invasion. Group A streptococcus, Staphylococcus aureus, and E. 
coli interact with integrin α5β1 via fibronectin to invade cells by actin 
rearrangement [87-89]. The type IV secretion system (T4SS) pilus-associated CagL 
of Helicobacter pylori binds to integrin α5β1 via its RGD motif [90]. However, 
CagY and CagA, which are components of the cag-T4SS, interact with β1 integrin 
independently of the RGD motif [91]. The Orientia tsutsugamushi outer membrane 
protein TSA56 interacts with integrin α5β1 via fibronectin for the invasion of host 
cells [92]. The bacterial surface of Porphyromonas gingivalis, a major 
periodontopathogen, binds to integrin α5β1 and is taken up into the cells via lipid 
rafts [93]. P. gingivalis type II fimbriae has a high affinity for integrin α5β1, 
causing marked adhesion of the bacteria to epithelial cells and high serum IL-1β 
levels in a mouse abscess model [94]. However, the role of integrin α5β1 in 
NLRP3 inflammasome activation has not yet been reported.  
This study showed that fibronectin, a representative integrin ligand, and the 
RGD peptide also activate caspase-1 via interaction with integrin α5β1 and ATP 
release, as was shown for Td92-induced caspase-1 activation. Because Td92 does 
not contain an RGD-motif, this motif is not required for the activation of caspase-1 
following the interaction of Td92 with integrin α5β1, indicating that the binding 
site for integrin α5β1 of Td92 is different from that of fibronectin or that of other 
RGD-containing proteins. Td92 can bind to cells via fibronectin, but this 
interaction does not seem to be critical for Td92-induced caspase-1 activation 
because a neutralizing anti-fibronectin Ab inhibited cell binding but not caspase-1 
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activation. Otherwise, the effect of Td92 on caspase-1 activation via fibronectin 
may be shielded by the direct interaction between Td92 and integrin α5β1. Further 
work to identify the sites through which Td92 binds to integrin α5β1 and 
fibronectin will yield new insight into the nature of the interaction between the 
integrin and its ligands that activates the NLRP3 inflammasome. Using the 
truncated Td92, it has been shown that the amino terminal half of Td92 possesses 
the activities for caspase-1 activation and proIL-1β expression.  
Td92 binding alone without internalization leads to NLRP3 activation, and 
proIL-1β expression has been shown using cytochalasin D, which inhibits actin 
polymerization. Interestingly, the clustering of integrin α5β1 induced by Td92 was 
not blocked by cytochalasin D. Buensuceso et al. [95] showed that fibrinogen 
binding to CHO cells stably expressing integrin αIIbβ3 induces αIIbβ3 clustering, 
which is not inhibited by cytochalasin D. These results were interpreted to mean 
that the actin cytoskeleton imposes basal constraints on fibrinogen binding function, 
and prevention of actin polymerization releases those constraints and increases 
ligand binding. Stable interaction between integrin αvβ3 and vitronectin was 
observed in the absence of actin polymerization [96]. 
Inflammation is essential for host defense against infections, but the chronic 
or excessive production of IL-1β by dysregulation of the inflammasome caused by 
mutations in NLRP3 and P2X7 is associated with heritable and acquired 
inflammatory diseases, such as type 2 diabetes, gout, and cryopyrin-associated 
periodic syndromes, including familial cold autoinflammatory syndrome, Muckle-
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Wells syndrome, and chronic infantile cutaneous neurological articular syndrome 
[35, 97-99]. IL-1β or IL-1β receptor antagonists are thus potential therapeutics for 
the treatment of inflammatory diseases through the targeting of the NLRP3 
activation pathway [100]. IL-1β is a key mediator for gingival inflammation and is 
a strong enhancer of tissue levels of PGE2 and TNF-α, leading to the degradation of 
the extracellular matrix of the periodontal tissues and alveolar bone, which are the 
characteristics of periodontitis [101]. Because IL-1β is tightly controlled by the 
separate regulation of transcription/translation and secretion, the simultaneous 
induction of proIL-1β and its maturation by Td92 could lead to uncontrollable 
inflammation. Td92 and homologous proteins are found in diverse oral Treponema 
species associated with periodontitis, and multiple Treponema species can be found 
in a single periodontitis patient or a single diseased site, implying that the 
coexistence of several Treponema species expressing Td92 homologous proteins 
could additively enhance IL-1β production, thus amplifying the cytopathological 
effects on host cells [102]. The significant reduction in T. denticola-induced IL-1β 
secretion upon the addition the integrin α5β1 Ab may indicate the specific 
contribution of Td92 to the overall T. denticola-induced IL-1β production. IL-1β is 
found at significantly higher levels in periodontal tissue and in the gingival 
crevicular fluid of periodontitis patients compared to healthy subjects, and its levels 
are markedly reduced after periodontal therapy [31, 103]. There is also a positive 
correlation between an IL-1β gene polymorphism and increased risk of developing 
periodontitis [104, 105].  
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ProIL-1β induction by microbial stimuli usually involves NF-κB activation, 
which is independent of inflammasome activation. However, a recent report 
demonstrated that proIL-1β induction also potentiated NLRP3 inflammasome 
activity by the NF-κB-dependent induction of NLRP3 in murine macrophages [64]. 
According to this report, the level of NLRP3 expression was critical for the 
activation of NLRP3 by its activators, including ATP, pore-forming toxins, and 
crystalline activators. NLRP3 activators alone cannot activate NLRP3 without the 
priming of the cells to stimulate NLRP3 transcription via transcriptionally active 
signaling receptors, such as TLRs and TNFR, which is dependent on the NF-κB 
signaling pathway. Consistent with this study, Td92 induced proIL-1β and NLRP3 
expression via NF-κB activity, which also affected caspase-1 activation. NLRP3 
mRNA expression in gingival tissues has been shown to be significantly higher in 
patients with gingivitis, chronic periodontitis, and generalized aggressive 
periodontitis than in periodontally healthy subjects, and the levels of NLRP3 
mRNA positively correlate with IL-1β mRNA [106]. Upon the infection of bone 
marrow-derived murine macrophages by Vibrio vulnificus or Vibrio cholerae, NF-
κB activation has been shown to be required for NLRP3 activation [107]. NF-κB 
activation for NLRP3 activation is TLR-dependent in V. vulnificus and TLR-
independent in V. cholera. However, the upregulation of NLRP3 expression was 
not observed with caspase-1 activation by these pathogens. Notably, ATP release 
was not found to be involved in NLRP3 activation by Vibrio infection. Td92-
induced NF-κB activation is TLR-independent. 
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The involvement of integrin α5β1 in the transcriptional regulation of IL-1β 
has been demonstrated in human promonocytic U937 cells through the activation 
of protein kinase C and the induction of AP-1 but not NF-κB [108]. Soluble 
fibronectin or a 120-kDa RGD-containing peptide obtained by chymotrypsin 
digestion of fibronectin induced IL-1β transcription via integrin α5β1 in U937 cells, 
and an RGD peptide inhibited fibronectin-induced IL-1β gene expression. 
Furthermore, an integrin α5 Ab alone induced IL-1β gene transcription, but the 
antibody did not enhance IL-1β expression when the cells were treated with 
fibronectin. Chen et al. [109] reported that RGD peptides, such as linear Arg-Gly-
Asp-Ser (RGDS) and cyclic Arg-Gly-Asp-Phe (RGDF), induced the mRNA 
expression of the interleukin-1β-converting enzyme (caspase-1) and apoptosis in 
the glomerular mesangial cells of adult human kidneys. Taken together, these 
results imply that integrin priming could lead to the induction of IL-1β expression. 
Although fibronectin and the RGD peptide induced caspase-1 activation in this 
study, they did not induce proIL-1β. The discrepancy between the present results 
and the results observed in previous studies using U937 cells and glomerular 
mesangial cells may be attributable to the different types of cells that were used or 
different doses of fibronectin used for cell treatment.  
A diverse variety of bacteria induce NLRP3 activation in the presence of ATP 
[110]. For example, P. gingivalis induces IL-1β synthesis in primary gingival 
epithelial cells, but IL-1β secretion via NLRP3 activation by the bacteria is 
dependent on the addition of ATP [58]. In contrast, Td92 triggers the release of 
ATP, which causes NLRP3 activation. The integrin α5β1 Ab inhibited Td92-
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induced ATP. ATP release induced by hypotonic stress has also been shown to be 
inhibited by the integrin α5β1 Ab in human umbilical cord vein endothelial cells, 
whereas ATP release induced by lysophosphatidic acid in the same cells was not 
affected by the Ab [111], even though hypotonic stress and lysophosphatidic acid 
use the same signaling molecules, RhoA/Rho-kinase and FAK/paxillin, to induce 
ATP release. This is because lysophosphatidic acid has a specific receptor that is 
not integrin α5β1. These results imply that integrin α5β1 binding is one mechanism 
for ATP release.  
Solini et al. [112] reported that the increased P2X7 reactivity and increased 
ATP release of fibroblasts from type 2 diabetes patients enhanced the intracellular 
accumulation and the extracellular release of fibronectin. Additionally, ATP caused 
increased YO-PRO uptake, cell swelling and shrinkage in the fibroblasts of type 2 
diabetes patients compared with cells from healthy subjects. Taken together, these 
results imply a possible connection between fibronectin and caspase-1 activation as 
well as cell death. However, a clear connection between these three components 
has been missing. In this study, the role of fibronectin in caspase-1 activation has 
been elucidated by demonstrating that the interaction between fibronectin and 
integrin α5β1 resulted in ATP release, which can cause caspase-1 activation and 
lead to cell death. It has been observed that fibronectin increased ATP release and 
vice versa. ATP release in response to fibronectin might be an autocrine or 
paracrine signal to stimulate further fibronectin expression, thereby resulting in 
enhanced caspase-1 activation.  
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Caspase-1 activation by Td92 is associated with membrane pore formation 
and the release of LDH, which are characteristics of pyroptosis, a proinflammatory 
cell death. Pyroptosis is an innate immune response to efficiently clear intracellular 
pathogens, including S. typhimurium and Legionella pneumophila, in a manner 
independent of proinflammatory cytokines, such as IL-1β and IL-18 [61]. Td92-
induced cell death is inhibited by the inhibitors of Td92-induced NLRP3 activation. 
T. denticola is not an intracellular organism, and persistent stimulation of cells with 
the T. denticola surface protein Td92 induces the related processes of IL-1β 
secretion and cell death, contributing to chronic nature of periodontitis.  
Currently, three models for NLRP3 activation have been proposed. In the 
channel model, the agonists activate the P2X7 ATP-gated ion channel, which 
triggers K+ efflux from the cells and recruits the pore-forming pannexin 1 
hemichannel. The agonists enter the cells through the pannexin 1 hemichannel and 
interact with NLRP3 in the cytoplasm [110, 113, 114]. In the lysosome rupture 
model, large particulate agonists, such as alum and silica, are inefficiently cleared 
from the host after phagocytosis, and the remaining particles induce phagosomal 
destabilization and lysosomal rupture, which allows the activation of NLRP3 via 
cathepsin B release [115, 116]. Finally, in the ROS model, all of the NLRP3 
agonists trigger the generation of a common component, possibly ROS, which 
leads to NLRP3 activation [56, 57, 59, 117, 118]. Because Td92-induced NLRP3 
activation includes ATP release from the host cells and K+ efflux, the channel 
model should be considered. However, the interaction of Td92 with a cell 
membrane receptor was sufficient to signal NLRP3 inflammation activation, and 
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Td92 internalization into the cytosol is not necessary. Therefore, the third model 
could possibly apply to Td92-induced NLRP3 activation. Td92-induced ROS have 
been observed. Although the activation of caspase-1 by Td92 is completely negated 
by the ATP antagonist oxATP, ROS production was only partially reduced by this 
compound. The elucidation of the mechanisms of NLRP3 activation via integrin 
priming to NF-κB activation may provide new insights into the process of NLRP3-
dependent caspase-1 activation.     
In summary, Tp92 homologs are surface-exposed outer membrane proteins 
that are common among the four oral Treponema species strongly associated with 
periodontitis. These proteins have the potential to bind to host cells and stimulate 
host factors that contribute to inflammation and osteoclastogenesis, which are 
major characteristics of periodontitis. As shown in Fig. 53, Td92 of T. denticola 
directly binds to integrin α5β1, which is a heterodimeric cell membrane receptor, 
leading to the activation of signaling pathways, such as the NF-κB pathway and the 
MAPK pathway, as well as ATP release. Activation of NF-κB and MAPK 
stimulate the expression of the IL-1β and NLRP3 genes, corresponding to the 
“signal 1”. ATP released by Td92 binds to the P2X7 receptor, which causes K+ 
efflux. Assembly of the NLRP3 inflammasome due to the K+ efflux results in 
autocatalytic cleavage of procaspase-1 to active caspase-1, corresponding to 
“signal 2”. The active caspase-1 can convert proIL-1β to its bioactive form and 
form pores in the plasma membrane. Thus, the active IL-1β can be secreted into the 
extracellular space. The simultaneous activation of IL-1β transcription and NLRP3 
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activation is required for IL-1β secretion, which can lead to uncontrolled IL-1β 
levels that may exaggerate inflammation, a characteristic of periodontitis. 
 
 
Figure 53. Integrin α5β1 is a principle receptor for the NLRP3 activation and 








The coexistence of various Treponema species in a single periodontal pocket 
may result in an accumulation of multiple Tp92 homologs and may amplify the 
pathological effects in periodontitis. The role of integrin α5β1 in NLRP3 activation 
by Td92 of T. denticola may provide new insight into understanding the activation 
and regulation of the inammasome. Strategies that control NLRP3 activation via 
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치주염과 관련된 구강나선균의 공통 표면단백질의 
병독력과 NLRP3 인플라마좀 활성 
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목적  
모든 구강나선균은 광범위한 다양성을 가진 Treponema종으로 구성되어 있고 
치주 병원성과 관련이 깊다. 다양한 종 또는 계통형의 Treponema가 한 환자와 
단일 치주낭에서 자주 발견되고 구강나선균의 존재는 질환의 중증도와 높은 
관련성을 나타낸다. 구강나선균의 몇 몇 외막단백질은 면역조절자로 중요하며 
이는 분자적 병인기전 연구로 증명된 바 있다. Tp92는 T. pallidum의 
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표면단백질로서 옵소닌 작용과 매독에 대한 방어적 면역반응을 유도한다고 
알려졌고 그람음성 세균에도 비슷한 기능을 가진 유사단백질이 있다. IL-1β는 
염증성 및 골흡수적인 특성을 가진 치주염의 면역병원성과 연관이 있고, 이는 
치주조직의 파괴를 야기한다. IL-1β는 선천면역을 구성하는 세포내 센서인 
인플라마좀 복합체 형성으로 생성된 활성형 caspase-1이 활성화시킨다. 이 
연구에서, 치주염과 관련된 4가지 주요한 구강나선균 (T. denticola, T. 
lecithinolyticum, T. maltophilum, T. socranskii subsp. socranskii)에 존재하는 Tp92 
유사단백질을 찾고 이들의 병인적 특성을 규명하였다.  
 실험 방법  
Tp92 유사단백질을 Esherichia coli에서 발현시키고 재조합단백질을 
정제하였다. Tp92 유사단백질의 부착능을 보기 위하여 편평세포 암종인 KB 
세포에 FITC를 붙인 Tp92 유사단백질 또는 carboxyfluorescein diacetate 
succinimidyl ester (CFSE)를 붙인 세균과 반응시켰다. Tp92 유사단백질들의 
교차반응은 T. denticola의 Td92에 대한 항혈청으로 확인하였다. Tp92 
유사단백질의 생리활성능 측정을 위하여 인간 단핵세포와 인간 치주인대 
세포에 반응시킨 후 염증 및 조직 파괴와 관련된 다양한 인자들을 분석하였다.  
T. denticola Td92에 의한 IL-1β 활성의 분자적 기전을 찾기 위하여 Td92를 
KCl, oxATP, K+ channel 억제자가 있거나 없는 상태에서 대식세포로 분화시킨 
세포에 자극시켰다. 이 세포에서 caspase-1 활성, proIL-1β, IL-1β의 분비를 
확인하였다. Td92에 의해 유도된 caspase-1 활성과 연관된 인플라마좀 구성분을 
찾기 위하여 NLRP3, ASC, NLRC4에 대한 siRNA를 사용하여 확인하였다. Td92에 
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의한 인플라마좀 활성에서 Td92의 세포내 유입이 필수적인 요인인지 확인하기 
위하여 단백질 유입시약이나 cytochalasin D를 사용하였다. 인플라마좀 활성과 
관련된 Td92의 세포내 수용체를 친화성 리간드 결합법으로 찾았다. 수용체와 
결합한 Td92가 proIL-1β 발현을 유도할 때 어떤 신호전달를 통하여 
이루어지는지를 확인하기 위하여 여러가지 억제제 또는 중성화 항체를 
처리하여 MAPK 경로 활성과 NF-κB 핵내이동 보았다. 
결과 
구강나선균의 Tp92 유사단백질은 신호 펩타이드 (20-31아미노산기)와 88-
92-kDa의 분자량을 가진다. 이 단백질에 대한 유전자를 E. coli에서 재조합 
형태로 발현시키고 정제하였다. Tp92 유사단백질은 KB세포에 부착하였고 
Td92에 의해 T. denticola의 세포 부착이 억제 되었다. T. lecithinolyticum, T. 
maltophilum, T. socranskii subsp. socranskii, 각각의 Tp92 유사단백질를 T. denticola 
Td92에 대한 항혈청(IgG)과 반응시켰을 때 교차반응을 나타냈다. Tp92 
유사단백질은 사람 단핵구와 인간 치주인대세포를 자극하여 IL-1β, IL-6, IL-8, 
TNF-α, COX-2, PGE2, MMP-9 등과 같은 염증 및 파골세포 형성 관련 인자들을 
유도하였다.  
대식세포를 T. denticola Td92로 자극하였을 때 ATP 방출과 K+이 유출되었고 
그 결과로써 caspase-1 활성, proIL-1β 발현, IL-1β 분비가 유도되었다. Td92의 
caspase-1 활성은 NLRP3 또는 ASC의 결핍에 의해 크게 줄었지만 NLRC4의 
결핍은 Td92의 caspase-1활성에 영향을 주지 않았다. Td92의 세포내 빠른 유입은 
Td92의 caspase-1 활성을 감소시켰으며 Td92의 유입 억제는 caspase-1과 proIL-1β 
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발현에 영향을 주지 않았다. 인테그린 α5β1이 T. denticola Td92에 대한 세포내 
수용체로서 NLRP3 인플라마좀을 활성화시키는데 중요한 역할을 하였다. Td92는 
인테그린 α5β1과 fibronectin에 모두 부착하였고 Td92에 의해 유도된 NLRP3 
인플라마좀 활성은 fibronectin과 관계없이 인테그린 α5β1과 직접 결합함으로써 
매개되었다. Td92와 인테그린 α5β1의 결합은 NF-κB에 활성을 통하여 proIL-1β 
발현, NLRP3 발현, caspase-1 활성을 유도하였다. 
결론 
Td92와 인테그린 α5β1의 직접적 상호작용이 NLRP3 인플라마즘 활성과 
proIL-1β를 합성함으로써 과도한 IL-1β 분비를 야기할 수 있다. 그러므로 
인테그린 α5β1은 Td92에 의한 NLRP3 인플라마좀 활성과 IL-1β 전사를 위한 
중요한 세포막의 수용체로 여겨지며, Td92와 인테그린 α5β1간의 상호작용에 
대한 이해는 치주염 치료를 위한 새로운 치료제 발전에 기여할 것이다. 
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